US20020169500A1 - Intravascular stent - Google Patents

Intravascular stent Download PDF

Info

Publication number
US20020169500A1
US20020169500A1 US10/123,889 US12388902A US2002169500A1 US 20020169500 A1 US20020169500 A1 US 20020169500A1 US 12388902 A US12388902 A US 12388902A US 2002169500 A1 US2002169500 A1 US 2002169500A1
Authority
US
United States
Prior art keywords
stent
expansion
column
connector
columns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/123,889
Inventor
G. Jang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Scimed Inc
Original Assignee
Jang G. David
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26689934&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20020169500(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/237,537 external-priority patent/US6235053B1/en
Priority claimed from US09/839,442 external-priority patent/US6409761B1/en
Application filed by Jang G. David filed Critical Jang G. David
Priority to US10/123,889 priority Critical patent/US20020169500A1/en
Publication of US20020169500A1 publication Critical patent/US20020169500A1/en
Assigned to SCIMED LIFE SYSTEMS, INC. reassignment SCIMED LIFE SYSTEMS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: G. DAVID JANG
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91525Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91558Adjacent bands being connected to each other connected peak to peak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0018Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in elasticity, stiffness or compressibility

Definitions

  • This invention relates to intravascular stents, and more particularly to an intravascular stent which provides easy introduction through tortious sections of vessels.
  • Angioplasty either coronary or general vascular
  • Balloon catheter dependent angioplasty has consistently proven to be the most reliable and practical interventional procedure.
  • Other ancillary technologies such as laser based treatment, or directional or rotational arthrectomy, have proven to be either of limited effectiveness or dependent on balloon angioplasty for completion of the intended procedure. Restenosis following balloon-based angioplasty is the most serious drawback and is especially prevalent in the coronary artery system.
  • Intravascular stenting noticeably reduces the restenosis rate following angioplasty procedures.
  • the procedure for intravascular stent placement typically involves pre-dilation of the target vessel using balloon angioplasty, followed by deployment of the stent, and expansion of the stent such that the dilated vessel walls are supported from the inside.
  • the intravascular stent functions as scaffolding for the lumen of a vessel.
  • the scaffolding of the vessel walls by the stent serve to: (a) prevent elastic recoil of the dilated vessel wall, (b) eliminate residual stenosis of the vessel; a common occurrence in balloon angioplasty procedures, (C) maintain the diameter of the stented vessel segment slightly larger than the native unobstructed vessel segments proximal and distal the stented segment and (d) as indicated by the latest clinical data, lower the restenosis rate.
  • the restenosis rate of stented vessels has proven significantly lower than for unstented or otherwise treated vessels; treatments include drug therapy and other methods mentioned previously.
  • Stenting has proven to be effective in some cases for treating impending closure of a vessel during angioplasty. Stenting can also control and stabilize an unstable local intimal tear of a vessel caused by normal conduct during an angioplasty procedure. In some cases, an incomplete or less than optimal dilatation of a vessel lesion with balloon angioplasty can successfully be opened up with a stent implant.
  • FIG. 1 An example of a conventional stent patent is U.S. Pat. No. 5,102,417 (hereafter the Palmaz Patent).
  • the stent described in the Palmaz Patent consists of a series of elongated tubular members having a plurality of slots disposed substantially parallel to the longitudinal axis of the tubular members.
  • the tubular members are connected by at least one flexible connector member.
  • the unexpanded tubular members of the Palmaz Patent are overly rigid so that practical application is limited to short lengths. Even with implementation of the multilink design with flexible connector members connecting a series of tubular members, longer stents can not navigate tortuous blood vessels. Furthermore, the rigidity of the unexpanded stent increases the risk of damaging vessels during insertion. Foreshortening of the stent during insertion complicates accurate placement of the stent and reduces the area that can be covered by the expanded stent. There is, further, no method of programming the stent diameter along its longitudinal axis to achieve a tapered expanded stent, and no method of reinforcement of stent ends or other regions is provided for.
  • WO 96/03092 Another example of a conventional stent patent is WO 96/03092, the Brun patent.
  • the stent described in the Brun patent is formed of a tube having a patterned shape, which has first and second meander patterns.
  • the even and odd first meander patterns are 180 degrees out of phase, with the odd patterns occurring between every two even patterns.
  • the second meander patterns run perpendicular to the first meander patterns, along the axis of the tube.
  • Adjacent first meander patterns are connected by second meander patterns to form a generally uniform distributed pattern.
  • the symmetrical arrangement with first and second meander patterns having sharp right angled bends allows for catching and snagging on the vessel wall during delivery.
  • the large convolutions in the second meander pattern are not fully straightened out during expansion reducing rigidity and structural strength of the expanded stent.
  • no method of programming the stent diameter along its longitudinal axis to achieve a tapering stent design, and no method of reinforcement of stent ends or other regions is provided for.
  • a stent with sufficient longitudinal flexibility in the unexpanded state to allow for navigation through tortuous vessels.
  • a stent that is structurally strong in the unexpanded state such that risk of damage or distortion during delivery is minimal.
  • a stent that is configured to expand to variable diameters along its length, such that a taper can be achieved in the expanded stent to match the natural taper of the target vessel.
  • an object of the present invention is to provide a scaffold for an interior lumen of a vessel.
  • Another object of the invention is to provide a stent which prevents recoil of the vessel following angioplasty.
  • a further object of the invention is to provide a stent that maintains a larger vessel lumen compared to the results obtained only with balloon angioplasty.
  • Yet another object of the invention is to provide a stent that reduces foreshortening of a stent length when expanded.
  • Another object of the invention is to provide a stent with increased flexibility when delivered to a selected site in a vessel.
  • a further object of the invention is to provide a stent with a low profile when crimped over a delivery balloon of a stent assembly.
  • Yet a further object of the invention is to provide a stent with reduced tupeling of the vessel wall.
  • Another object of the invention is to provide a chain mesh stent that reduces vessel “hang up” in a tortious vessel or a vessel with curvature.
  • a stent in a nonexpanded state with a first column expansion strut pair A plurality of the first column expansion strut pair form a first expansion column. A plurality of second column expansion strut pair form a second expansion column. A plurality of first serial connecting struts form a first connecting strut column that couples the first expansion column to the second expansion column.
  • the first expansion column, the second expansion column, and the first connecting strut column form a plurality of geometric cells. At least a portion of the plurality are asymmetrical geometric cells.
  • At least a portion of the first connecting struts include a proximal section, a distal section a first linear section and a first slant angle.
  • a first expansion strut in the first expansion column is circumferentially offset from a corresponding second expansion strut of the second expansion column.
  • FIG. 1A is a side elevation view of the pre-expansion mode of an embodiment of the stent of the present invention
  • FIG. 1B is a cross sectional view of an embodiment of the stent of the present invention.
  • FIG. 1C is a longitudinal cross sectional view of an embodiment of the stent of the present invention.
  • FIG. 2A is a scale drawing of the strut pattern of an embodiment of the stent of the present invention.
  • FIG. 2B is an expanded view of a section of the pattern of FIG. 2A.
  • FIG. 3A is a schematic illustration of a the pre-expansion mode of an embodiment of the stent of the present invention.
  • FIG. 3B is a schematic illustration of the post-expansion mode of an embodiment of the stent of the present invention.
  • FIG. 4A is a scale drawing including dimensions of an embodiment of the stent of the present invention.
  • FIG. 4B is an enlarged section of the scale drawing of FIG. 4A.
  • FIG. 5 is a scale drawing of an embodiment of the stent of the present invention with a tapered diameter in its post-expansion mode.
  • FIG. 6A is a scale drawing of an embodiment of the stent of the present invention with reinforcement expansion columns.
  • FIG. 6B is a perspective view of the embodiment of FIG. 6A.
  • FIG. 7A is a scale drawing of an embodiment of the stent of the present invention including relief notches at strut joints to increase flexibility of the joints.
  • FIG. 7B is an enlarged region of the embodiment of FIG. 7A.
  • FIG. 7C is an enlarged view of a single connecting strut joining two expansion strut pairs in accordance with the embodiment of FIG. 7A.
  • FIG. 8A is a drawing of an alternate geometry of connecting struts and joining struts in accord with the present invention.
  • FIG. 8B is a drawing of an alternate geometry of connecting struts and joining struts in accord with the present invention.
  • FIG. 8C is a drawing of an alternate geometry of connecting struts and joining struts in accord with the present invention.
  • FIG. 8D is a drawing of an alternate geometry of connecting struts and joining struts in accord with the present invention.
  • FIG. 8E is a drawing of an alternate geometry of connecting struts and joining struts in accord with the present invention.
  • FIG. 9 is a delivery balloon catheter, illustrating a method of deliver of a stent in accord with the present invention.
  • FIGS. 1A, 1B, 1 C, 2 A and 2 B A first embodiment of the present invention is shown in FIGS. 1A, 1B, 1 C, 2 A and 2 B.
  • FIG. 1A an elongate hollow tubular stent 10 in an unexpanded state is shown.
  • a proximal end 12 and a distal end 14 define a longitudinal length 16 of stent 10 .
  • the longitudinal length 16 of the stent 10 can be as long as 100 mm. or longer.
  • a proximal opening 18 and a distal opening 20 connect to an inner lumen 22 of stent 10 .
  • Stent 10 can be a single piece, without any seams or welding joints or may include multiple pieces.
  • Stent 10 is constructed of two to fifty or more expansion columns or rings 24 connected together by interspersed connecting strut columns 26 .
  • the first column on the proximal end 12 and the last column on the distal. end 14 of stent 10 are expansion columns 24 .
  • Expansion columns 24 are formed from a series of expansion struts 28 , and joining struts 30 .
  • Expansion struts 28 are thin elongate members arranged so that they extend at least in part in the direction of the longitudinal axis of stent 10 .
  • expansion struts 28 are reoriented such that they extend in a more circumferential direction, Le along the surface of cylindrical stent 10 and perpendicular to its longitudinal axis. Reorientation of expansion struts 28 causes stent 10 to have an expanded circumference and diameter.
  • expansion struts 28 of unexpanded stent 10 are seen to extend substantially parallel to the longitudinal axis of stent 10 .
  • Expansion struts 28 are joined together by joining struts 30 to form a plurality of expansion strut pairs 32 .
  • Expansion strut pairs have a closed end 34 and an open end 36 .
  • Additional joining struts 30 join together expansion struts 28 of adjacent expansion strut pairs 32 , such that expansion struts 28 are joined alternately at their proximal and distal ends to adjacent expansion struts 28 to form expansion columns 24 .
  • Each expansion column 24 contains a plurality, typically eight to twenty, twenty to sixty, or larger of expansion struts 28 .
  • Connecting struts 38 connect adjacent expansion columns 24 forming a series of interspersed connecting strut columns 26 each extending around the circumference of stent 10 .
  • Each connecting strut 38 joins a pair of expansion struts 28 in an expansion column 24 to an adjacent pair of expansion struts 28 in an adjacent expansion column 24 .
  • the ratio of expansion struts 28 in an expansion column 24 to connecting struts 38 in a connecting strut column 26 is two to one; however, this ratio in general can be x to 1 where x is greater or less than two.
  • 1A begins with an expansion column 24 on the proximal end 12 and ends with an expansion column 24 on the distal end 14 , if there are n expansion columns 24 with m expansion struts 28 per column, there will be m ⁇ 1 connecting strut columns 26 , and n(m1)/2 connecting struts 38 .
  • connecting struts 38 in each connecting strut column 26 allows stent 10 to be longitudinally flexibility. Longitudinal flexibility can be further increased by using a narrow width connecting strut, providing additional flexibility and suppleness to the stent as it is navigated around turns in a natural blood vessel.
  • a cell space is an empty region on the surface of stent 10 , completed surrounded by one or a combination of stent struts, including expansion struts 28 , connecting struts 38 , or joining struts 30 .
  • Asymmetrical cell spaces 40 are cell spaces which have no geometrical symmetry i.e. no rotation, reflection, combination rotation and reflection or other symmetry.
  • Asymmetrical cell spaces 40 in FIG. 1A are surrounded by a first expansion strut pair 32 in a first expansion column 24 , a first connecting strut 38 , a second expansion strut pair 32 in an adjacent expansion column 24 , a first joining strut 30 , a second connecting strut 38 , and a second joining strut 30 .
  • expansion strut pairs 32 of asymmetrical cell space 40 may be circumferentially offset i.e. have longitudinal axes that are not collinear and have their open ends 36 facing each other.
  • the space between two expansion struts of an expansion strut pair 32 is known as a loop slot 42 .
  • FIG. 1B shows inner lumen 22 , radius 44 and stent wall 46 of stent 10 .
  • Stent wall 46 consists of stent struts including expansion struts 28 , connecting struts 38 and joining struts 30 .
  • FIG. 1C shows, proximal end 12 , distal end 14 , longitudinal length 16 , inner lumen 22 , and stent wall 46 of stent 10 .
  • Inner lumen 22 is surrounded by stent wall 46 which forms the cylindrical surface of stent 10 .
  • joining struts 30 of stent 10 are seen to extend at an angle to the expansion struts 28 , forming a narrow angle 48 with one expansion strut 28 in an expansion strut pair 32 and a wide angle 50 with the other expansion strut 28 of an expansion strut pair 32 .
  • Narrow angle 48 is less than ninety degrees
  • wide angle 50 is greater than ninety degrees.
  • Joining struts 30 extend both longitudinally along the longitudinal axis of stent 10 and circumferentially, along the surface of the stent 10 perpendicular its longitudinal axis.
  • Expansion strut spacing 52 between adjacent expansion struts 28 in a given expansion column 24 are uniform in stent 10 of FIGS. 2A and 2B; however, nonuniform spacings can also be used. Expansion strut spacings 52 can be varied, for example, spacings 52 between adjacent expansion struts 28 in an expansion column 24 can alternate between a narrow and a wide spacing. Additionally, spacings 52 in a single expansion column 24 can differ from other spacings 52 in other columns 24 .
  • FIGS. 2A and 2B show an arrangement of expansion struts 28 such that collinear, parallel adjacent loop slots 42 are formed, but non-collinear and non-parallel loop slots 42 can also be used.
  • loop slots 42 need not be the same among loop slots of a single or multiple expansion columns 24 .
  • the shape a loop slots 42 can be altered by changing the orientation or physical dimensions of the expansion struts 28 and/or joining struts 30 which connect expansion struts 28 of expansion strut pairs 32 defining the boundaries of loop slots 42 .
  • Connecting struts 38 couple adjacent expansion columns 24 , by connecting the distal. end of an expansion strut pair in one expansion column 24 to the proximal end of an adjacent expansion strut pair 32 in a second expansion column 24 .
  • Connecting struts 38 of FIGS. 2A and 2B are formed from two linear sections, a first linear section 5 4 being joined at its distal end to a second linear section 56 at its proximal end to form a first slant angle 58 .
  • first linear section 54 of a connecting strut 38 is joined to expansion strut 28 at the point where joining strut 30 makes narrow angle 48 with expansion strut 28 .
  • First linear section 54 extends substantially collinear to joining strut 30 continuing the line of joining strut 30 into the space between expansion columns 24 .
  • the distal end of the first linear section 54 is joined to the proximal end of the second linear section 56 forming slant angle 58 .
  • Second linear section 56 extends substantially parallel to expansion struts 28 connecting at its distal. end to joining strut 30 in an adjacent expansion column 24 .
  • the distal end of second linear section 56 attaches to expansion strut 28 at the point where joining strut 30 makes narrow angle 48 with expansion strut 28 .
  • joining strut 30 can have a second slant angle with a width that can be the same or different from the width of the first slant angle.
  • FIGS. 2A and 2B show connecting struts 38 and joining struts 30 slanted relative to the longitudinal axis of stent 10 , with the circumferential direction of the slanted struts alternating from column to adjacent column.
  • Circumferential direction refers to the handedness with which the slanted struts wind about the surface of the stent 10 .
  • the circumferential direction of the slant of connecting strut first linear sections 54 in a connecting strut column 26 is opposite the circumferential direction of the slant of connecting strut first linear sections 54 in an adjacent connecting strut column 26 .
  • circumferential direction of the slant of joining struts 30 in an expansion column 24 is opposite the circumferential direction of the slant of joining struts 30 in an adjacent expansion column 24 .
  • Alternating circumferential slant directions of connecting struts 38 and joining struts 30 prevents axial warping of stent 10 during deliver and expansion.
  • Other non-alternating slant direction patterns can also be used for connecting struts 38 or joining struts 30 or both.
  • FIG. 3A and 3B show a schematic illustration of a stent design according to the present invention in an unexpanded and expanded state respectively.
  • the design is depicted as a flat projection, as if stent 10 were cut lengthwise parallel to its longitudinal axis and flattened out.
  • the connecting struts 38 consist of first and second linear sections 54 and 56 forming slant angle 58 at pivot point 60 .
  • An asymmetrical cell space 40 is formed by expansion strut pairs 32 , connecting struts 38 and joining; struts 30 . Multiple interlocking asymmetrical cell spaces 40 make up the design pattern.
  • the expansion strut pairs 32 spread apart at their open ends 36 , shortening the length of expansion struts 28 along the longitudinal axis of the cylindrical stent.
  • the longitudinal shortening of expansion struts 28 during expansion is countered by the longitudinal lengthening of connecting struts 38 .
  • the widening of slant angle 58 during expansion straightens connecting struts 38 and lengthens the distance between the coupled expansion strut pairs 32 .
  • the lengthening of the distance between coupled expansion strut pairs 32 substantially compensates for the longitudinal shortening of expansion struts 28 .
  • the stent has substantially constant unexpanded and expanded longitudinal lengths.
  • each expansion column 24 becomes circumferentially stretched, enlarging the space between struts.
  • the interlinking of expansion columns 24 by connecting struts 38 that have been straightened through the expansion process gives the stent 10 a high radial support strength.
  • the entire stent 10 when expanded is unitized into a continuous chain mesh of stretched expansion columns 24 and connecting strut columns 26 forming an asymmetrical interlocking cell geometry which resists collapse both axially and radially. When the stent is expanded it has increased rigidity and fatigue tolerance.
  • connecting struts 38 at pivot points 60 allows increased longitudinal flexibility of the stent.
  • the tangent plane of a specific connecting strut 38 refers to the plane substantially tangent to the cylindrical surface of the stent at that connecting strut 38 .
  • the width of connecting struts 38 is typically two to four, or more times the thickness, which makes connecting struts 38 relatively inflexible when bending in their tangent plane.
  • pivot points 60 in connecting struts 38 provide connecting struts 38 a flexible joint about which to more easily bend increasing longitudinal flexibility of the stent.
  • stent 10 has a length 16 of 33.25 mm and an uncrimped and unexpanded circumference 88 of 5.26 mm.
  • Fifteen expansion columns 24 are interspersed with connecting strut columns 26 .
  • Each expansion column 24 consists of twelve expansion struts 28 joined alternately at their proximal and distal ends by joining struts 30 forming six expansion strut pairs 32 .
  • Expansion struts 28 are aligned parallel to the longitudinal axis of cylindrical stent 10 .
  • Joining struts 30 form a narrow angle 48 and a wide angle 50 with the respective expansion struts 28 of expansion strut pairs 32 .
  • Adjacent expansion columns 24 employ alternating circumferential slant directions of joining struts 30 .
  • expansion strut width 62 is 0.20 mm
  • expansion strut length 64 is 1.51 mm
  • connecting strut width 66 is 0.13 mm.
  • Distance 68 from the outer edge of a first expansion strut 28 to the outer edge of a second adjacent expansion strut 28 in the same expansion column 24 is 0.64 mm, leaving a loop slot width 70 of 0.24 mm.
  • connecting struts 38 consist of a slanted first linear section 54 joined to a second linear section 56 at a slant angle 58 .
  • First linear section 54 is slightly longer than second linear section 56 and is attached at its proximal end to an expansion strut 28 in an expansion column 24 .
  • the attachment of the proximal end of first linear section 54 to expansion strut 28 is at the point where joining strut 30 makes narrow angle 48 with expansion strut 28 .
  • First linear section 54 extends substantially collinear to joining strut 30 attaching at its distal end to the proximal end of second linear section 56 to form slant angle 58 .
  • Second linear section 56 extends substantially collinear to expansion struts 28 , attaching at its distal end to an expansion strut 28 in an adjacent expansion column 24 . The attachment occurs at the point where expansion strut 28 forms narrow angle 48 with joining strut 30 . Joining struts 30 and connecting strut first linear sections 54 slant in alternating circumferential directions from column to adjacent column.
  • connecting struts 38 and expansion struts 28 at the point where narrow angle 48 is formed aids smooth delivery of stent 10 by streamlining the surface of the unexpanded stent and minimizing possible catching points. Bare delivery of stent 10 to the target lesion in a vessel will thus result in minimal snagging or catching as it is navigated through turns and curvatures in the vessel. Stent 10 behaves like a flexible, tubular sled as it is moved forward or backward in the vessel on the delivery catheter, sliding through tortuous vessels and over irregular bumps caused by atherosclerotic plaques inside the vessel lumen.
  • Stent 10 of FIGS. 4A and 4B has an internal diameter of up to 5.0 mm, while maintaining an acceptable radial strength and fatigue tolerance.
  • the crimped stent outer diameter can be as small as 1.0 mm or less depending on the condition of the underlying delivery balloon profile; A small crimped outer diameter is especially important if stent delivery is to be attempted without predilation of the target site.
  • the surface of the crimped stent is smooth allowing for no snagging of the stent struts during either forward or backward movement through a vessel.
  • FIG. 5 shows a second embodiment of the present invention in which the stent 10 in its expanded form has a gradual taper from proximal end 12 to distal end 14 .
  • the shaded segments 72 , 74 , 76 , 78 , 80 , 82 and 84 of expansion struts 28 represent regions of expansion struts 28 to be removed. Removal of the shaded segments 72 , 74 , 76 , 78 , 80 , 82 and 84 provides stent 10 with a gradual taper when expanded with distal end 14 having a smaller expanded diameter than proximal end 12 .
  • the degree of shortening of the expanded diameter of the stent 10 at a given expansion column 24 will be proportional to the length of the removed segment 72 , 74 , 76 , 78 , 80 , 82 , or 84 at that expansion column 24 .
  • the shortened expansion struts 28 will have a shortened component along the circumference of the stent resulting in a shortened circumference and diameter.
  • the tapered diameter portion can be positioned anywhere along the length of stent 10 , and the tapering can be made more or less gradual by removing appropriately larger or smaller portions of the expansion struts 28 in a given expansion column 24 .
  • Tapering is especially important in long stents, longer than 12 mm, since tapering of blood vessels is more pronounced over longer lengths.
  • a long stent with a uniform stent diameter can only be matched to the target vessel diameter over a short region. If the proximal vessel size is matched with the stent diameter, the expanded distal end of the stent will be too large for the natural vessel and may cause an intimal dissection of the distal. vessel by stent expansion. On the other hand, if the distal vessel size is matched with the stent diameter, the proximal end of the expanded stent will be too small to set inside the vessel lumen. It is therefore desirable to have a stent with a tapered expanded diameter.
  • Another way achieve a tapered expanded stent is to change the stiffness of the stent struts, expansion struts, connecting struts or joining struts such that the stiffness of the struts varies along the length of the stent.
  • the stiffness of the struts can be changed by altering length, width or thickness, adding additional stiffening material, using a chemical or mechanical means to alter the physical properties of the stent material, or applying one or a series of elastic elements about the stent.
  • a matching tapered balloon catheter would ideally be made for delivery and deployment of the tapered diameter stent.
  • the method of using a tapered matching balloon catheter with a tapered diameter stent is within the scope of the present invention.
  • Using a tapered balloon to expand a non-tapered stent will also achieve a tapered expanded stent; however, since no metal is removed from the stent, the stent is tapered as a result of incomplete expansion. The stent will therefore have increased metal fraction at the tapered end resulting in increased risk of acute thrombosis. Metal fraction is the proportion of the surface of the expanded stent covered by the stent strut material. Shortening the expansion struts as shown in FIG. 5 allows for a tapered expanded stent with substantially constant metal fraction along its length.
  • a third embodiment of the present invention shown in FIGS. 6A and 6B has multiple reinforcement expansion columns 86 placed along the length of the stent 10 .
  • the reinforcement columns 86 are placed along the stent length to provide additional localized radial strength and rigidity to stent 10 . Additional strength and rigidity are especially important at the ends of the stent to prevent deformation of the stent both during delivery and after placement. During delivery the stent ends can catch on the vessel wall possibly deforming the unexpanded stent and altering its expansion characteristics.
  • the catheter or guidewire can catch on the stent ends pulling the stent away from the vessel wall and possibly damaging and/or blocking the vessel.
  • the specific variation of the third embodiment of stent 10 depicted in FIGS. 6A and 6B has a length 16 of 20.70 mm and an uncrimped and unexpanded circumference 88 of 5.26 mm.
  • the stent 10 consists of six expansion columns 24 and three reinforcement expansion columns 86 , each consisting respectively of twelve expansion struts 28 or reenforcement expansion struts 90 .
  • the reenforcement expansion columns 86 are positioned one at either end, and one along the length of the stent 10 .
  • the expansion strut width 62 is 0.15 mm
  • reenforcement expansion strut width 92 is 0.20 mm
  • the connecting strut width 66 is 0.10 mm.
  • the narrow angle 48 formed by joining strut 30 and expansion strut 28 is 75 degrees
  • the narrow angle 94 formed by reenforcement joining strut 96 and reenforcement expansion strut 90 is 60 degrees.
  • reenforcement expansion columns 86 can also be used and fall within the scope of the present invention.
  • a taper can also be programmed into the reenforced stent 10 by shortening expansion struts 28 and reenforcement expansion struts 90 in appropriate expansion columns 24 and 86 .
  • a fourth embodiment of the present invention is similar to the third embodiment but has the added feature of relief notches 98 and 100 .
  • a relief notch is a notch where metal has been removed from a strut, usually at a joint where multiple struts are connected. Relief notches increase flexibility of a strut or joint by creating a thinned, narrow region along the strut or joint.
  • Relief notch 98 is formed at the joint formed between first linear section 54 of connecting strut 38 and expansion strut 28 .
  • Relief notch 100 is formed at the joint between second linear section 56 of connecting strut 38 and expansion strut 28 .
  • the positioning of the relief notches gives added flexibility to the unexpanded stent. Relief notches can be placed at other joints and can be included in any of the previously mentioned embodiments.
  • FIG. 8A shows a rounded loop connecting strut 38 which joins two circumferentially offset expansion strut pairs 32 in adjacent expansion columns. Expansion struts 28 in each expansion strut pair 32 are joined by a joining strut 30 . Joining struts 30 are slanted such as to form a narrow angle 48 and a wide angle 50 with the expansion struts 28 they connect.
  • the rounded loop connecting strut 38 connects expansion struts 28 at the point where narrow angle is formed between expansion strut 28 and joining strut 30 .
  • the slopes of the rounded connecting strut 38 at its proximal end 102 and distal. end 104 substantially match the slopes of the joining struts 30 connecting the pairs of expansion struts 28 .
  • the rounded loop connecting strut 38 thus blends smoothly into the joining struts 30 .
  • the rounded loop connecting strut 38 has a first radius of curvature 106 and a second radius of curvature 108 .
  • a rounded loop connecting strut 38 joins two circumferentially offset expansion strut pairs 32 in adjacent expansion columns. Expansion struts 28 in each expansion strut pair 32 are joined by a joining strut 30 . Joining struts 30 are at right angles to the expansion struts 28 they connect. The rounded loop connecting strut 38 connects to expansion struts 28 at the same point as joining struts 30 .
  • the rounded connecting strut 38 has a first radius of curvature 106 and a second radius of curvature 108 such that it connects circumferentially offset expansion strut pairs 32 .
  • connecting strut 38 joins two circumferentially offset expansion strut pairs 32 in adjacent expansion columns. Expansion struts 28 in each expansion strut pair 32 are joined by a joining strut 30 . Joining struts 30 are slanted such as to form a narrow angle 48 and a wide angle 50 with the expansion struts 28 they connect.
  • the connecting strut 38 connects expansion struts 28 at the point where narrow angle 48 is formed between expansion strut 28 and joining strut 30 .
  • the connecting strut 38 is made up of three linear sections 110 , 112 , and 114 forming two slant angles 116 and 118 .
  • the proximal end of section 110 is attached to expansion strut 28 at the point where joining strut 30 forms narrow angle 48 with expansion strut 28 .
  • Section 110 extends substantially collinear to joining strut 30 and is attached at its distal end to section 112 forming slant angle 116 .
  • Section 112 extends at an angle to section 110 such that section 112 is substantially parallel to expansion struts 28 and is connected at its distal end to the proximal end of section 114 forming slant angle 118 .
  • Section 114 extends at an angle such that it is substantially collinear to joining strut 30 of the adjacent expansion strut pair 32 .
  • Section 114 attaches at its distal end to expansion strut 28 of the adjacent expansion strut pair 32 , at the point where joining strut 30 forms narrow angle 48 with expansion strut 28 .
  • a connecting strut 38 joins two circumferentially offset expansion strut pairs 32 in adjacent expansion columns. Expansion struts 28 in each expansion strut pair 32 are joined by a joining strut 30 . Joining struts 30 are at right angles to the expansion struts 28 they connect. The connecting strut 38 connects to expansion struts 28 at the same point as joining struts 30 .
  • the connecting struts 38 of FIGS. 8D and 8E are made up of multiple connecting strut sections connected end to end to form a jagged connecting strut 38 with multiple slant angles, coupling expansion strut pair 32 to adjacent expansion strut pair 32 .
  • the connecting strut of FIG. 8D is made up of three connecting strut sections 120 , 122 , and 124 with two slant angles 126 and 128
  • the connecting strut of FIG. 8E consists of four connecting strut sections 130 , 132 , 134 , and 136 with three slant angles 138 , 140 and 142 .
  • the connecting strut section 134 can be modified by replacing connecting strut section 136 by the dotted connecting strut section 144 to give another possible geometry of connecting struts 38 .
  • the stent of the present invention is ideally suited for application in coronary vessels although versatility in the stent design allows for applications in non-coronary vessels, the aorta, and nonvascular tubular body organs.
  • Typical coronary vascular stents have expanded diameters that range from 2.5 to 5.0 mm.
  • a stent with high radial strength and fatigue tolerance that expands to a 5.0 mm diameter may have unacceptably high stent metal fraction when used in smaller diameter vessels. If the stent metal fraction is high, the chances of acute thrombosis and restenosis potential will increase. Even with the same metal fraction a smaller caliber vessel is more likely than a larger one to have a high rate of thrombosis.
  • stents for coronary application for example, small vessels stents for use in vessels with diameters from 2.5 mm, to 3.0 mm, and large vessel stents for use in vessels with diameters from 3.0 mm. to 5.0 mm.
  • small vessels stents for use in vessels with diameters from 2.5 mm, to 3.0 mm
  • large vessel stents for use in vessels with diameters from 3.0 mm. to 5.0 mm.
  • both small vessels and large vessels when treated with the appropriate sized stent will contain stents of similar idealized metal fraction.
  • the stent of the present invention can be made using a CAM-driven laser cutting system to cut the stent pattern from a stainless steel tube.
  • the rough-cut stent is preferably electro-polished to remove surface imperfections and sharp edges.
  • Other methods of fabricating the stent can also be used such as EDM, photo-electric etching technology, or other methods.
  • Any suitable material can be used for the stent including other metals and polymers so long as they provide the essential structural strength, flexibility, biocompatibility and expandability.
  • the stent is typically at least partially plated with a radiopaque metal, such as gold, platinum, tantalum or other suitable metal. It is preferred to plate only both ends of the stent by localized plating; however, the entire stent or other regions can also be plated. When plating both ends, one to three or more expansion columns on each end of the stent are plated to mark the ends of the stent so they can be identified under fluoroscopy during the stenting procedure. By plating the stent only at the ends, interference of the radiopaque plating material with performance characteristics or surface modulation of the stent frame is minimized. Additionally the amount of plating material required is reduced, lowering the material cost of the stent.
  • a radiopaque metal such as gold, platinum, tantalum or other suitable metal.
  • the stent is cleaned, typically with detergent, saline and ultrasonic means that are well-known in the art.
  • the stents are then inspected for quality control, assembled with the delivery balloon catheter, and properly packaged, labeled, and sterilized.
  • the stent can be marketed as stand alone or as a pre-mounted delivery balloon catheter assembly as shown in FIG. 9.
  • the stent 10 is crimped over a folded balloon 146 at the distal end 148 of a delivery balloon catheter assembly 150 .
  • the assembly 150 includes a proximal end adapter 152 , a catheter shaft 154 , a balloon channel 156 , a guidewire channel 158 , a balloon 146 , and a guidewire 160 .
  • Balloon 146 can be tapered in an expanded state, be curved from a proximal end to a distal end in the expanded state. Additionally stent 10 can be non-tapered or tapered in the expanded state.
  • the guidewire 160 is inserted into the vein or artery and advanced to the target site.
  • the catheter shaft 154 is then forwarded over the guidewire 160 to position the stent 10 and balloon 146 into position at the target site.
  • the balloon 146 is inflated through the balloon channel 156 to expand the stent 10 from a crimped to an expanded state.
  • the stent 10 provides the desired scaffolding support to the vessel.
  • the balloon 146 is deflated and the catheter shaft 154 , balloon 146 , and guidewire 160 are withdrawn from the patient.
  • the stent of the present invention can be made as short as less than 10 mm in length or as long as 100 mm or more. If long stents are to be used, however, matching length delivery catheter balloons will typically be needed to expand the stents into their deployed positions. Long stents, depending on the target vessel, may require curved long balloons for deployment. Curved balloons which match the natural curve of a blood vessel reduce stress on the blood vessel during stent deployment. This is especially important in many coronary applications which involve stenting in curved coronary vessels. The use of such curved balloons is within the scope of the present invention.

Abstract

A stent in a non-expanded state has a first column expansion strut pair. A plurality of the first column expansion strut pair form a first expansion column. A plurality of second column expansion strut pair form a second expansion column. A plurality of first serial connecting struts form a first connecting strut column that couples the first expansion column to the second expansion column. The first expansion column, the second expansion column, and the first connecting strut column form a plurality of geometric cells. At least a portion of the plurality are asymmetrical geometric cells.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. Ser. No. 09/839,442 filed Apr. 20, 2001 which is a continuation of U.S. Pat. No. 6,241,760 which claims the benefit of U.S. Ser. No. 60/017,484 filed Apr. 26, 1996. This application is also a continuation of U.S. Ser. No. 09/839,287 filed Apr. 20, 2001 which is a continuation of U.S. Ser. No. 09/237,537 filed Jan. 26, 1999 which claims the benefit of U.S. Ser. No. 60/073,412 filed Feb. 2, 1998, all of which applications are incorporated herein by reference.[0001]
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention [0002]
  • This invention relates to intravascular stents, and more particularly to an intravascular stent which provides easy introduction through tortious sections of vessels. [0003]
  • 2. Description of the Related Art [0004]
  • Angioplasty, either coronary or general vascular, has advanced to become the most effective means for revascularization of stenosed vessels. In the early 1980's, angioplasty first became available for clinical practice in the coronary artery, and has since proven an effective alterative to conventional bypass graft surgery. Balloon catheter dependent angioplasty has consistently proven to be the most reliable and practical interventional procedure. Other ancillary technologies such as laser based treatment, or directional or rotational arthrectomy, have proven to be either of limited effectiveness or dependent on balloon angioplasty for completion of the intended procedure. Restenosis following balloon-based angioplasty is the most serious drawback and is especially prevalent in the coronary artery system. [0005]
  • Many regimens have been designed to combat restenosis, with limited success, including laser based treatment and directional or rotational arthrectomy. Intravascular stenting, however, noticeably reduces the restenosis rate following angioplasty procedures. The procedure for intravascular stent placement typically involves pre-dilation of the target vessel using balloon angioplasty, followed by deployment of the stent, and expansion of the stent such that the dilated vessel walls are supported from the inside. [0006]
  • The intravascular stent functions as scaffolding for the lumen of a vessel. The scaffolding of the vessel walls by the stent serve to: (a) prevent elastic recoil of the dilated vessel wall, (b) eliminate residual stenosis of the vessel; a common occurrence in balloon angioplasty procedures, (C) maintain the diameter of the stented vessel segment slightly larger than the native unobstructed vessel segments proximal and distal the stented segment and (d) as indicated by the latest clinical data, lower the restenosis rate. Following an angioplasty procedure, the restenosis rate of stented vessels has proven significantly lower than for unstented or otherwise treated vessels; treatments include drug therapy and other methods mentioned previously. [0007]
  • Another benefit of vessel stenting is the potential reduction of emergency bypass surgery arising from angioplasty procedures. Stenting has proven to be effective in some cases for treating impending closure of a vessel during angioplasty. Stenting can also control and stabilize an unstable local intimal tear of a vessel caused by normal conduct during an angioplasty procedure. In some cases, an incomplete or less than optimal dilatation of a vessel lesion with balloon angioplasty can successfully be opened up with a stent implant. [0008]
  • Early in its development, the practice of stenting, especially in coronary arteries, had serious anticoagulation problems. However, anticoagulation techniques have since been developed and are becoming simpler and more effective. Better and easier to use regimens are continuously being introduced, including simple outpatient anticoagulation treatments, resulting in reduced hospital stays for stent patients. [0009]
  • An example of a conventional stent patent is U.S. Pat. No. 5,102,417 (hereafter the Palmaz Patent). The stent described in the Palmaz Patent consists of a series of elongated tubular members having a plurality of slots disposed substantially parallel to the longitudinal axis of the tubular members. The tubular members are connected by at least one flexible connector member. [0010]
  • The unexpanded tubular members of the Palmaz Patent are overly rigid so that practical application is limited to short lengths. Even with implementation of the multilink design with flexible connector members connecting a series of tubular members, longer stents can not navigate tortuous blood vessels. Furthermore, the rigidity of the unexpanded stent increases the risk of damaging vessels during insertion. Foreshortening of the stent during insertion complicates accurate placement of the stent and reduces the area that can be covered by the expanded stent. There is, further, no method of programming the stent diameter along its longitudinal axis to achieve a tapered expanded stent, and no method of reinforcement of stent ends or other regions is provided for. [0011]
  • Another example of a conventional stent patent is WO 96/03092, the Brun patent. The stent described in the Brun patent is formed of a tube having a patterned shape, which has first and second meander patterns. The even and odd first meander patterns are 180 degrees out of phase, with the odd patterns occurring between every two even patterns. The second meander patterns run perpendicular to the first meander patterns, along the axis of the tube. [0012]
  • Adjacent first meander patterns are connected by second meander patterns to form a generally uniform distributed pattern. The symmetrical arrangement with first and second meander patterns having sharp right angled bends allows for catching and snagging on the vessel wall during delivery. Furthermore, the large convolutions in the second meander pattern are not fully straightened out during expansion reducing rigidity and structural strength of the expanded stent. There is, further, no method of programming the stent diameter along its longitudinal axis to achieve a tapering stent design, and no method of reinforcement of stent ends or other regions is provided for. [0013]
  • These and other conventional stent designs suffer in varying degrees from a variety of drawbacks including: (a) inability to negotiate bends in vessels due to columnar rigidity of the unexpanded stent; (b) lack of structural strength, radial and axial lateral, of the unexpanded stent; (c) significant foreshortening of the stent during expansion; (d) limited stent length; (e) constant expanded stent diameter; (f) poor crimping characteristics; and (g) rough surface modulation of the unexpanded stent. [0014]
  • There is a need for a stent with sufficient longitudinal flexibility in the unexpanded state to allow for navigation through tortuous vessels. There is a further need for a stent that is structurally strong in the unexpanded state such that risk of damage or distortion during delivery is minimal. A further need exists for a stent that maintains substantially the same longitudinal length during expansion to allow greater coverage at the target site and simplify proper placement of the stent. Yet a further need exists for a stent design with sufficient longitudinal flexibility that long stents of up to 100 mm can be safely delivered through tortuous vessels. There is a need for a stent that is configured to expand to variable diameters along its length, such that a taper can be achieved in the expanded stent to match the natural taper of the target vessel. A need exists for a stent which, (i) can be crimped tightly on the expansion balloon while maintaining a low profile and flexibility, (ii) has a smooth surface modulation when crimped over a delivery balloon, to prevent catching and snagging of the stent on the vessel wall during delivery or (iii) with reinforcement rings on the ends or middle or both to keep the ends of the stent securely positioned against the vessel walls of the target blood vessel. [0015]
  • SUMMARY OF THE INVENTION
  • Accordingly an object of the present invention is to provide a scaffold for an interior lumen of a vessel. [0016]
  • Another object of the invention is to provide a stent which prevents recoil of the vessel following angioplasty. [0017]
  • A further object of the invention is to provide a stent that maintains a larger vessel lumen compared to the results obtained only with balloon angioplasty. [0018]
  • Yet another object of the invention is to provide a stent that reduces foreshortening of a stent length when expanded. [0019]
  • Another object of the invention is to provide a stent with increased flexibility when delivered to a selected site in a vessel. [0020]
  • A further object of the invention is to provide a stent with a low profile when crimped over a delivery balloon of a stent assembly. [0021]
  • Yet a further object of the invention is to provide a stent with reduced tupeling of the vessel wall. [0022]
  • Another object of the invention is to provide a chain mesh stent that reduces vessel “hang up” in a tortious vessel or a vessel with curvature. [0023]
  • These and other objects of the invention are achieved in a stent in a nonexpanded state with a first column expansion strut pair. A plurality of the first column expansion strut pair form a first expansion column. A plurality of second column expansion strut pair form a second expansion column. A plurality of first serial connecting struts form a first connecting strut column that couples the first expansion column to the second expansion column. The first expansion column, the second expansion column, and the first connecting strut column form a plurality of geometric cells. At least a portion of the plurality are asymmetrical geometric cells. [0024]
  • In another embodiment, at least a portion of the first connecting struts include a proximal section, a distal section a first linear section and a first slant angle. [0025]
  • It yet another embodiment, a first expansion strut in the first expansion column is circumferentially offset from a corresponding second expansion strut of the second expansion column.[0026]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1A is a side elevation view of the pre-expansion mode of an embodiment of the stent of the present invention; [0027]
  • FIG. 1B is a cross sectional view of an embodiment of the stent of the present invention; [0028]
  • FIG. 1C is a longitudinal cross sectional view of an embodiment of the stent of the present invention; [0029]
  • FIG. 2A is a scale drawing of the strut pattern of an embodiment of the stent of the present invention. [0030]
  • FIG. 2B is an expanded view of a section of the pattern of FIG. 2A. [0031]
  • FIG. 3A is a schematic illustration of a the pre-expansion mode of an embodiment of the stent of the present invention. [0032]
  • FIG. 3B is a schematic illustration of the post-expansion mode of an embodiment of the stent of the present invention. [0033]
  • FIG. 4A is a scale drawing including dimensions of an embodiment of the stent of the present invention. [0034]
  • FIG. 4B is an enlarged section of the scale drawing of FIG. 4A. [0035]
  • FIG. 5 is a scale drawing of an embodiment of the stent of the present invention with a tapered diameter in its post-expansion mode. [0036]
  • FIG. 6A is a scale drawing of an embodiment of the stent of the present invention with reinforcement expansion columns. [0037]
  • FIG. 6B is a perspective view of the embodiment of FIG. 6A. [0038]
  • FIG. 7A is a scale drawing of an embodiment of the stent of the present invention including relief notches at strut joints to increase flexibility of the joints. [0039]
  • FIG. 7B is an enlarged region of the embodiment of FIG. 7A. [0040]
  • FIG. 7C is an enlarged view of a single connecting strut joining two expansion strut pairs in accordance with the embodiment of FIG. 7A. [0041]
  • FIG. 8A is a drawing of an alternate geometry of connecting struts and joining struts in accord with the present invention. [0042]
  • FIG. 8B is a drawing of an alternate geometry of connecting struts and joining struts in accord with the present invention. [0043]
  • FIG. 8C is a drawing of an alternate geometry of connecting struts and joining struts in accord with the present invention. [0044]
  • FIG. 8D is a drawing of an alternate geometry of connecting struts and joining struts in accord with the present invention. [0045]
  • FIG. 8E is a drawing of an alternate geometry of connecting struts and joining struts in accord with the present invention. [0046]
  • FIG. 9 is a delivery balloon catheter, illustrating a method of deliver of a stent in accord with the present invention.[0047]
  • DETAILED DESCRIPTION
  • A first embodiment of the present invention is shown in FIGS. 1A, 1B, [0048] 1C, 2A and 2B. Referring to FIG. 1A, an elongate hollow tubular stent 10 in an unexpanded state is shown. A proximal end 12 and a distal end 14 define a longitudinal length 16 of stent 10. The longitudinal length 16 of the stent 10 can be as long as 100 mm. or longer. A proximal opening 18 and a distal opening 20 connect to an inner lumen 22 of stent 10. Stent 10 can be a single piece, without any seams or welding joints or may include multiple pieces.
  • [0049] Stent 10 is constructed of two to fifty or more expansion columns or rings 24 connected together by interspersed connecting strut columns 26. The first column on the proximal end 12 and the last column on the distal. end 14 of stent 10 are expansion columns 24.
  • [0050] Expansion columns 24 are formed from a series of expansion struts 28, and joining struts 30. Expansion struts 28 are thin elongate members arranged so that they extend at least in part in the direction of the longitudinal axis of stent 10. When an outward external force is applied to stent 10 from the inside by an expansion balloon or other means, expansion struts 28 are reoriented such that they extend in a more circumferential direction, Le along the surface of cylindrical stent 10 and perpendicular to its longitudinal axis. Reorientation of expansion struts 28 causes stent 10 to have an expanded circumference and diameter. In FIG. 1A, expansion struts 28 of unexpanded stent 10 are seen to extend substantially parallel to the longitudinal axis of stent 10.
  • Expansion struts [0051] 28 are joined together by joining struts 30 to form a plurality of expansion strut pairs 32. Expansion strut pairs have a closed end 34 and an open end 36. Additional joining struts 30 join together expansion struts 28 of adjacent expansion strut pairs 32, such that expansion struts 28 are joined alternately at their proximal and distal ends to adjacent expansion struts 28 to form expansion columns 24. Each expansion column 24 contains a plurality, typically eight to twenty, twenty to sixty, or larger of expansion struts 28.
  • Connecting [0052] struts 38 connect adjacent expansion columns 24 forming a series of interspersed connecting strut columns 26 each extending around the circumference of stent 10. Each connecting strut 38 joins a pair of expansion struts 28 in an expansion column 24 to an adjacent pair of expansion struts 28 in an adjacent expansion column 24. For stent 10 of FIG. 1A, the ratio of expansion struts 28 in an expansion column 24 to connecting struts 38 in a connecting strut column 26 is two to one; however, this ratio in general can be x to 1 where x is greater or less than two. Furthermore, since the stent 10 of FIG. 1A begins with an expansion column 24 on the proximal end 12 and ends with an expansion column 24 on the distal end 14, if there are n expansion columns 24 with m expansion struts 28 per column, there will be m−1 connecting strut columns 26, and n(m1)/2 connecting struts 38.
  • The reduced number of connecting [0053] struts 38 in each connecting strut column 26, as compared to expansion struts 28 in each expansion column 24, allows stent 10 to be longitudinally flexibility. Longitudinal flexibility can be further increased by using a narrow width connecting strut, providing additional flexibility and suppleness to the stent as it is navigated around turns in a natural blood vessel.
  • At least a portion of the open spaces between struts in [0054] stent 10 form asymmetrical cell spaces 40. A cell space is an empty region on the surface of stent 10, completed surrounded by one or a combination of stent struts, including expansion struts 28, connecting struts 38, or joining struts 30. Asymmetrical cell spaces 40 are cell spaces which have no geometrical symmetry i.e. no rotation, reflection, combination rotation and reflection or other symmetry.
  • [0055] Asymmetrical cell spaces 40 in FIG. 1A are surrounded by a first expansion strut pair 32 in a first expansion column 24, a first connecting strut 38, a second expansion strut pair 32 in an adjacent expansion column 24, a first joining strut 30, a second connecting strut 38, and a second joining strut 30. Furthermore, expansion strut pairs 32 of asymmetrical cell space 40 may be circumferentially offset i.e. have longitudinal axes that are not collinear and have their open ends 36 facing each other. The space between two expansion struts of an expansion strut pair 32 is known as a loop slot 42.
  • FIG. 1B shows [0056] inner lumen 22, radius 44 and stent wall 46 of stent 10. Stent wall 46 consists of stent struts including expansion struts 28, connecting struts 38 and joining struts 30.
  • FIG. 1C shows, [0057] proximal end 12, distal end 14, longitudinal length 16, inner lumen 22, and stent wall 46 of stent 10. Inner lumen 22 is surrounded by stent wall 46 which forms the cylindrical surface of stent 10.
  • Referring now to FIGS. 2A and 2B, joining [0058] struts 30 of stent 10 are seen to extend at an angle to the expansion struts 28, forming a narrow angle 48 with one expansion strut 28 in an expansion strut pair 32 and a wide angle 50 with the other expansion strut 28 of an expansion strut pair 32. Narrow angle 48 is less than ninety degrees, while wide angle 50 is greater than ninety degrees. Joining struts 30 extend both longitudinally along the longitudinal axis of stent 10 and circumferentially, along the surface of the stent 10 perpendicular its longitudinal axis.
  • [0059] Expansion strut spacing 52 between adjacent expansion struts 28 in a given expansion column 24 are uniform in stent 10 of FIGS. 2A and 2B; however, nonuniform spacings can also be used. Expansion strut spacings 52 can be varied, for example, spacings 52 between adjacent expansion struts 28 in an expansion column 24 can alternate between a narrow and a wide spacing. Additionally, spacings 52 in a single expansion column 24 can differ from other spacings 52 in other columns 24.
  • It is noted that varying [0060] expansion strut spacings 52 which form the loop slots 42 results in variable loop slot widths. Furthermore, the longitudinal axis of the loop slots 42 need not be collinear or even parallel with the longitudinal axis of loop slots 42 of an adjacent expansion column 24. FIGS. 2A and 2B show an arrangement of expansion struts 28 such that collinear, parallel adjacent loop slots 42 are formed, but non-collinear and non-parallel loop slots 42 can also be used.
  • Additionally the shape of [0061] loop slots 42 need not be the same among loop slots of a single or multiple expansion columns 24. The shape a loop slots 42 can be altered by changing the orientation or physical dimensions of the expansion struts 28 and/or joining struts 30 which connect expansion struts 28 of expansion strut pairs 32 defining the boundaries of loop slots 42.
  • Connecting [0062] struts 38 couple adjacent expansion columns 24, by connecting the distal. end of an expansion strut pair in one expansion column 24 to the proximal end of an adjacent expansion strut pair 32 in a second expansion column 24. Connecting struts 38 of FIGS. 2A and 2B are formed from two linear sections, a first linear section 5 4 being joined at its distal end to a second linear section 56 at its proximal end to form a first slant angle 58.
  • The first [0063] linear section 54 of a connecting strut 38 is joined to expansion strut 28 at the point where joining strut 30 makes narrow angle 48 with expansion strut 28. First linear section 54 extends substantially collinear to joining strut 30 continuing the line of joining strut 30 into the space between expansion columns 24. The distal end of the first linear section 54 is joined to the proximal end of the second linear section 56 forming slant angle 58. Second linear section 56 extends substantially parallel to expansion struts 28 connecting at its distal. end to joining strut 30 in an adjacent expansion column 24. The distal end of second linear section 56 attaches to expansion strut 28 at the point where joining strut 30 makes narrow angle 48 with expansion strut 28. Further, joining strut 30 can have a second slant angle with a width that can be the same or different from the width of the first slant angle.
  • FIGS. 2A and 2B show connecting struts [0064] 38 and joining struts 30 slanted relative to the longitudinal axis of stent 10, with the circumferential direction of the slanted struts alternating from column to adjacent column. Circumferential direction refers to the handedness with which the slanted struts wind about the surface of the stent 10. The circumferential direction of the slant of connecting strut first linear sections 54 in a connecting strut column 26 is opposite the circumferential direction of the slant of connecting strut first linear sections 54 in an adjacent connecting strut column 26. Similarly, the circumferential direction of the slant of joining struts 30 in an expansion column 24 is opposite the circumferential direction of the slant of joining struts 30 in an adjacent expansion column 24. Alternating circumferential slant directions of connecting struts 38 and joining struts 30 prevents axial warping of stent 10 during deliver and expansion. Other non-alternating slant direction patterns can also be used for connecting struts 38 or joining struts 30 or both.
  • FIG. 3A and 3B show a schematic illustration of a stent design according to the present invention in an unexpanded and expanded state respectively. The design is depicted as a flat projection, as if [0065] stent 10 were cut lengthwise parallel to its longitudinal axis and flattened out. The connecting struts 38 consist of first and second linear sections 54 and 56 forming slant angle 58 at pivot point 60. An asymmetrical cell space 40 is formed by expansion strut pairs 32, connecting struts 38 and joining; struts 30. Multiple interlocking asymmetrical cell spaces 40 make up the design pattern.
  • As the stent is expanded, see FIG. 3B, the expansion strut pairs [0066] 32 spread apart at their open ends 36, shortening the length of expansion struts 28 along the longitudinal axis of the cylindrical stent. The longitudinal shortening of expansion struts 28 during expansion is countered by the longitudinal lengthening of connecting struts 38. The widening of slant angle 58 during expansion straightens connecting struts 38 and lengthens the distance between the coupled expansion strut pairs 32. The lengthening of the distance between coupled expansion strut pairs 32 substantially compensates for the longitudinal shortening of expansion struts 28. Thus, the stent has substantially constant unexpanded and expanded longitudinal lengths.
  • When the stent is expanded, each [0067] expansion column 24 becomes circumferentially stretched, enlarging the space between struts. The interlinking of expansion columns 24 by connecting struts 38 that have been straightened through the expansion process gives the stent 10 a high radial support strength. The entire stent 10 when expanded is unitized into a continuous chain mesh of stretched expansion columns 24 and connecting strut columns 26 forming an asymmetrical interlocking cell geometry which resists collapse both axially and radially. When the stent is expanded it has increased rigidity and fatigue tolerance.
  • In addition, efficient bending and straightening of connecting [0068] struts 38 at pivot points 60 allows increased longitudinal flexibility of the stent. For the stent to bend longitudinally, at least some of connecting struts 38 are forced to bend in their tangent plane. The tangent plane of a specific connecting strut 38 refers to the plane substantially tangent to the cylindrical surface of the stent at that connecting strut 38. The width of connecting struts 38 is typically two to four, or more times the thickness, which makes connecting struts 38 relatively inflexible when bending in their tangent plane. However, pivot points 60 in connecting struts 38 provide connecting struts 38 a flexible joint about which to more easily bend increasing longitudinal flexibility of the stent.
  • Referring to FIGS. 4A and 4B, a variation of the first embodiment of [0069] stent 10 of the present invention is shown. In this variation, stent 10 has a length 16 of 33.25 mm and an uncrimped and unexpanded circumference 88 of 5.26 mm. Fifteen expansion columns 24 are interspersed with connecting strut columns 26. Each expansion column 24 consists of twelve expansion struts 28 joined alternately at their proximal and distal ends by joining struts 30 forming six expansion strut pairs 32. Expansion struts 28 are aligned parallel to the longitudinal axis of cylindrical stent 10. Joining struts 30 form a narrow angle 48 and a wide angle 50 with the respective expansion struts 28 of expansion strut pairs 32. Adjacent expansion columns 24 employ alternating circumferential slant directions of joining struts 30.
  • In this variation of the first embodiment, expansion strut width [0070] 62 is 0.20 mm, expansion strut length 64 is 1.51 mm, and connecting strut width 66 is 0.13 mm. Distance 68 from the outer edge of a first expansion strut 28 to the outer edge of a second adjacent expansion strut 28 in the same expansion column 24 is 0.64 mm, leaving a loop slot width 70 of 0.24 mm.
  • In this variation of the first embodiment, connecting [0071] struts 38 consist of a slanted first linear section 54 joined to a second linear section 56 at a slant angle 58. First linear section 54 is slightly longer than second linear section 56 and is attached at its proximal end to an expansion strut 28 in an expansion column 24. The attachment of the proximal end of first linear section 54 to expansion strut 28 is at the point where joining strut 30 makes narrow angle 48 with expansion strut 28. First linear section 54 extends substantially collinear to joining strut 30 attaching at its distal end to the proximal end of second linear section 56 to form slant angle 58. Second linear section 56 extends substantially collinear to expansion struts 28, attaching at its distal end to an expansion strut 28 in an adjacent expansion column 24. The attachment occurs at the point where expansion strut 28 forms narrow angle 48 with joining strut 30. Joining struts 30 and connecting strut first linear sections 54 slant in alternating circumferential directions from column to adjacent column.
  • The joining of connecting [0072] struts 38 and expansion struts 28 at the point where narrow angle 48 is formed aids smooth delivery of stent 10 by streamlining the surface of the unexpanded stent and minimizing possible catching points. Bare delivery of stent 10 to the target lesion in a vessel will thus result in minimal snagging or catching as it is navigated through turns and curvatures in the vessel. Stent 10 behaves like a flexible, tubular sled as it is moved forward or backward in the vessel on the delivery catheter, sliding through tortuous vessels and over irregular bumps caused by atherosclerotic plaques inside the vessel lumen.
  • When fully expanded [0073] Stent 10 of FIGS. 4A and 4B has an internal diameter of up to 5.0 mm, while maintaining an acceptable radial strength and fatigue tolerance. The crimped stent outer diameter can be as small as 1.0 mm or less depending on the condition of the underlying delivery balloon profile; A small crimped outer diameter is especially important if stent delivery is to be attempted without predilation of the target site. When the stent is optimally crimped over the delivery balloon, the surface of the crimped stent is smooth allowing for no snagging of the stent struts during either forward or backward movement through a vessel.
  • FIG. 5 shows a second embodiment of the present invention in which the [0074] stent 10 in its expanded form has a gradual taper from proximal end 12 to distal end 14. The shaded segments 72, 74, 76, 78, 80, 82 and 84 of expansion struts 28 represent regions of expansion struts 28 to be removed. Removal of the shaded segments 72, 74, 76, 78, 80, 82 and 84 provides stent 10 with a gradual taper when expanded with distal end 14 having a smaller expanded diameter than proximal end 12. The degree of shortening of the expanded diameter of the stent 10 at a given expansion column 24 will be proportional to the length of the removed segment 72, 74, 76, 78, 80, 82, or 84 at that expansion column 24. In the expanded stent 10 the shortened expansion struts 28 will have a shortened component along the circumference of the stent resulting in a shortened circumference and diameter. The tapered diameter portion can be positioned anywhere along the length of stent 10, and the tapering can be made more or less gradual by removing appropriately larger or smaller portions of the expansion struts 28 in a given expansion column 24. Tapering is especially important in long stents, longer than 12 mm, since tapering of blood vessels is more pronounced over longer lengths. A long stent with a uniform stent diameter can only be matched to the target vessel diameter over a short region. If the proximal vessel size is matched with the stent diameter, the expanded distal end of the stent will be too large for the natural vessel and may cause an intimal dissection of the distal. vessel by stent expansion. On the other hand, if the distal vessel size is matched with the stent diameter, the proximal end of the expanded stent will be too small to set inside the vessel lumen. It is therefore desirable to have a stent with a tapered expanded diameter.
  • Another way achieve a tapered expanded stent is to change the stiffness of the stent struts, expansion struts, connecting struts or joining struts such that the stiffness of the struts varies along the length of the stent. The stiffness of the struts can be changed by altering length, width or thickness, adding additional stiffening material, using a chemical or mechanical means to alter the physical properties of the stent material, or applying one or a series of elastic elements about the stent. [0075]
  • Along with the use of a tapered diameter stent, a matching tapered balloon catheter would ideally be made for delivery and deployment of the tapered diameter stent. The method of using a tapered matching balloon catheter with a tapered diameter stent is within the scope of the present invention. [0076]
  • Using a tapered balloon to expand a non-tapered stent will also achieve a tapered expanded stent; however, since no metal is removed from the stent, the stent is tapered as a result of incomplete expansion. The stent will therefore have increased metal fraction at the tapered end resulting in increased risk of acute thrombosis. Metal fraction is the proportion of the surface of the expanded stent covered by the stent strut material. Shortening the expansion struts as shown in FIG. 5 allows for a tapered expanded stent with substantially constant metal fraction along its length. [0077]
  • A third embodiment of the present invention shown in FIGS. 6A and 6B has multiple [0078] reinforcement expansion columns 86 placed along the length of the stent 10. The reinforcement columns 86 are placed along the stent length to provide additional localized radial strength and rigidity to stent 10. Additional strength and rigidity are especially important at the ends of the stent to prevent deformation of the stent both during delivery and after placement. During delivery the stent ends can catch on the vessel wall possibly deforming the unexpanded stent and altering its expansion characteristics. After the stent has been placed it is important that the stent ends are rigid so that they set firmly against the vessel wall, otherwise, during a subsequent catheter procedure, the catheter or guidewire can catch on the stent ends pulling the stent away from the vessel wall and possibly damaging and/or blocking the vessel.
  • The specific variation of the third embodiment of [0079] stent 10 depicted in FIGS. 6A and 6B has a length 16 of 20.70 mm and an uncrimped and unexpanded circumference 88 of 5.26 mm. The stent 10 consists of six expansion columns 24 and three reinforcement expansion columns 86, each consisting respectively of twelve expansion struts 28 or reenforcement expansion struts 90. The reenforcement expansion columns 86 are positioned one at either end, and one along the length of the stent 10.
  • The expansion strut width [0080] 62 is 0.15 mm, reenforcement expansion strut width 92 is 0.20 mm, and the connecting strut width 66 is 0.10 mm. The narrow angle 48 formed by joining strut 30 and expansion strut 28 is 75 degrees, and the narrow angle 94 formed by reenforcement joining strut 96 and reenforcement expansion strut 90 is 60 degrees.
  • Other arrangements of [0081] reenforcement expansion columns 86, such as providing reenforcement expansion columns 86 only on the ends of the stent, only on one end, or at multiple locations throughout the length of the stent can also be used and fall within the scope of the present invention. A taper can also be programmed into the reenforced stent 10 by shortening expansion struts 28 and reenforcement expansion struts 90 in appropriate expansion columns 24 and 86.
  • A fourth embodiment of the present invention, shown in the FIGS. 7A, 7B and [0082] 7C, is similar to the third embodiment but has the added feature of relief notches 98 and 100. A relief notch is a notch where metal has been removed from a strut, usually at a joint where multiple struts are connected. Relief notches increase flexibility of a strut or joint by creating a thinned, narrow region along the strut or joint. Relief notch 98 is formed at the joint formed between first linear section 54 of connecting strut 38 and expansion strut 28. Relief notch 100 is formed at the joint between second linear section 56 of connecting strut 38 and expansion strut 28. The positioning of the relief notches gives added flexibility to the unexpanded stent. Relief notches can be placed at other joints and can be included in any of the previously mentioned embodiments.
  • FIGS. 8A, 8B, [0083] 8C, 8D and 8E illustrates some examples of alternate connecting strut designs which can be used in any of the previously discussed embodiments. FIG. 8A shows a rounded loop connecting strut 38 which joins two circumferentially offset expansion strut pairs 32 in adjacent expansion columns. Expansion struts 28 in each expansion strut pair 32 are joined by a joining strut 30. Joining struts 30 are slanted such as to form a narrow angle 48 and a wide angle 50 with the expansion struts 28 they connect. The rounded loop connecting strut 38 connects expansion struts 28 at the point where narrow angle is formed between expansion strut 28 and joining strut 30. The slopes of the rounded connecting strut 38 at its proximal end 102 and distal. end 104 substantially match the slopes of the joining struts 30 connecting the pairs of expansion struts 28. The rounded loop connecting strut 38 thus blends smoothly into the joining struts 30. Additionally the rounded loop connecting strut 38 has a first radius of curvature 106 and a second radius of curvature 108.
  • In the design of FIG. 8B a rounded [0084] loop connecting strut 38 joins two circumferentially offset expansion strut pairs 32 in adjacent expansion columns. Expansion struts 28 in each expansion strut pair 32 are joined by a joining strut 30. Joining struts 30 are at right angles to the expansion struts 28 they connect. The rounded loop connecting strut 38 connects to expansion struts 28 at the same point as joining struts 30. The rounded connecting strut 38 has a first radius of curvature 106 and a second radius of curvature 108 such that it connects circumferentially offset expansion strut pairs 32.
  • In the design of FIG. [0085] 8C connecting strut 38 joins two circumferentially offset expansion strut pairs 32 in adjacent expansion columns. Expansion struts 28 in each expansion strut pair 32 are joined by a joining strut 30. Joining struts 30 are slanted such as to form a narrow angle 48 and a wide angle 50 with the expansion struts 28 they connect. The connecting strut 38 connects expansion struts 28 at the point where narrow angle 48 is formed between expansion strut 28 and joining strut 30.
  • The connecting [0086] strut 38 is made up of three linear sections 110, 112, and 114 forming two slant angles 116 and 118. The proximal end of section 110 is attached to expansion strut 28 at the point where joining strut 30 forms narrow angle 48 with expansion strut 28. Section 110 extends substantially collinear to joining strut 30 and is attached at its distal end to section 112 forming slant angle 116. Section 112 extends at an angle to section 110 such that section 112 is substantially parallel to expansion struts 28 and is connected at its distal end to the proximal end of section 114 forming slant angle 118. Section 114 extends at an angle such that it is substantially collinear to joining strut 30 of the adjacent expansion strut pair 32. Section 114 attaches at its distal end to expansion strut 28 of the adjacent expansion strut pair 32, at the point where joining strut 30 forms narrow angle 48 with expansion strut 28.
  • In the design of FIGS. 8D and 8E a connecting [0087] strut 38 joins two circumferentially offset expansion strut pairs 32 in adjacent expansion columns. Expansion struts 28 in each expansion strut pair 32 are joined by a joining strut 30. Joining struts 30 are at right angles to the expansion struts 28 they connect. The connecting strut 38 connects to expansion struts 28 at the same point as joining struts 30.
  • The connecting struts [0088] 38 of FIGS. 8D and 8E are made up of multiple connecting strut sections connected end to end to form a jagged connecting strut 38 with multiple slant angles, coupling expansion strut pair 32 to adjacent expansion strut pair 32. The connecting strut of FIG. 8D is made up of three connecting strut sections 120, 122, and 124 with two slant angles 126 and 128, while the connecting strut of FIG. 8E consists of four connecting strut sections 130, 132, 134, and 136 with three slant angles 138, 140 and 142. In addition, the connecting strut section 134 can be modified by replacing connecting strut section 136 by the dotted connecting strut section 144 to give another possible geometry of connecting struts 38.
  • One skilled in the art will recognize that there are many possible arrangements of connecting struts and joining struts consistent with the present invention; the above examples are not intended to be an exhaustive list. [0089]
  • The stent of the present invention is ideally suited for application in coronary vessels although versatility in the stent design allows for applications in non-coronary vessels, the aorta, and nonvascular tubular body organs. [0090]
  • Typical coronary vascular stents have expanded diameters that range from 2.5 to 5.0 mm. However, a stent with high radial strength and fatigue tolerance that expands to a 5.0 mm diameter may have unacceptably high stent metal fraction when used in smaller diameter vessels. If the stent metal fraction is high, the chances of acute thrombosis and restenosis potential will increase. Even with the same metal fraction a smaller caliber vessel is more likely than a larger one to have a high rate of thrombosis. It is, therefore, preferred to have at least two different categories of stents for coronary application, for example, small vessels stents for use in vessels with diameters from 2.5 mm, to 3.0 mm, and large vessel stents for use in vessels with diameters from 3.0 mm. to 5.0 mm. Thus, both small vessels and large vessels when treated with the appropriate sized stent will contain stents of similar idealized metal fraction. [0091]
  • The stent of the present invention can be made using a CAM-driven laser cutting system to cut the stent pattern from a stainless steel tube. The rough-cut stent is preferably electro-polished to remove surface imperfections and sharp edges. Other methods of fabricating the stent can also be used such as EDM, photo-electric etching technology, or other methods. Any suitable material can be used for the stent including other metals and polymers so long as they provide the essential structural strength, flexibility, biocompatibility and expandability. [0092]
  • The stent is typically at least partially plated with a radiopaque metal, such as gold, platinum, tantalum or other suitable metal. It is preferred to plate only both ends of the stent by localized plating; however, the entire stent or other regions can also be plated. When plating both ends, one to three or more expansion columns on each end of the stent are plated to mark the ends of the stent so they can be identified under fluoroscopy during the stenting procedure. By plating the stent only at the ends, interference of the radiopaque plating material with performance characteristics or surface modulation of the stent frame is minimized. Additionally the amount of plating material required is reduced, lowering the material cost of the stent. [0093]
  • After plating, the stent is cleaned, typically with detergent, saline and ultrasonic means that are well-known in the art. The stents are then inspected for quality control, assembled with the delivery balloon catheter, and properly packaged, labeled, and sterilized. [0094]
  • The stent can be marketed as stand alone or as a pre-mounted delivery balloon catheter assembly as shown in FIG. 9. Referring to FIG. 9, the [0095] stent 10 is crimped over a folded balloon 146 at the distal end 148 of a delivery balloon catheter assembly 150. The assembly 150 includes a proximal end adapter 152, a catheter shaft 154, a balloon channel 156, a guidewire channel 158, a balloon 146, and a guidewire 160. Balloon 146 can be tapered in an expanded state, be curved from a proximal end to a distal end in the expanded state. Additionally stent 10 can be non-tapered or tapered in the expanded state.
  • Typically the [0096] guidewire 160 is inserted into the vein or artery and advanced to the target site. The catheter shaft 154 is then forwarded over the guidewire 160 to position the stent 10 and balloon 146 into position at the target site. Once in position the balloon 146 is inflated through the balloon channel 156 to expand the stent 10 from a crimped to an expanded state. In the expanded state, the stent 10 provides the desired scaffolding support to the vessel. Once the stent 10 has been expanded, the balloon 146 is deflated and the catheter shaft 154, balloon 146, and guidewire 160 are withdrawn from the patient.
  • The stent of the present invention can be made as short as less than 10 mm in length or as long as 100 mm or more. If long stents are to be used, however, matching length delivery catheter balloons will typically be needed to expand the stents into their deployed positions. Long stents, depending on the target vessel, may require curved long balloons for deployment. Curved balloons which match the natural curve of a blood vessel reduce stress on the blood vessel during stent deployment. This is especially important in many coronary applications which involve stenting in curved coronary vessels. The use of such curved balloons is within the scope of the present invention. [0097]
  • The foregoing description of a preferred embodiment of the invention has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise forms disclosed. Obviously, many modifications and variations will be apparent to practitioners skilled in this art. It is intended that the scope of the invention be defined by the following claims and their equivalents.[0098]

Claims (48)

What is claimed is:
1. A tubular stent in an unexpanded state configured to transform into a tapered tubular form when expanded and having a plurality of expansion columns and connector columns arranged along a longitudinal axis in a horizontal plane, comprising:
a plurality of unbroken expansion ring columns having expansion strut pairs, the plurality of expansion ring columns including an unbroken first expansion ring column made of a plurality of first expansion strut pairs each having a first expansion strut and an adjacent second expansion strut, and a second unbroken expansion ring column made of a plurality of second expansion strut pairs each having a first expansion strut and an adjacent second expansion strut, expansion strut pairs of each expansion ring column of the plurality of expansion ring columns having geometric configurations similar to the first expansion ring column or the second expansion ring column, each unbroken expansion ring column having a progressively narrower horizontal width from a proximal end to the distal end of the stent along the longitudinal axis and each unbroken expansion ring column having a same circumferential diameter, wherein expansion strut pairs in each unbroken expansion ring column have a progressively shorter length from one expansion ring column to a next expansion column from the proximal end to the distal end of the stent.
a plurality of connector columns that couple adjacent expansion columns, the plurality of connector columns including a first connector column that couples the first expansion column to the second expansion column, wherein each connector column of the plurality of connector columns having at least a first connector strut, and each first connector strut has at least a portion with a shaped configuration.
2. The stent of claim 1, wherein the stent is tapered when nominally expanded.
3. The stent of claim 1, wherein a tapered stent has progressively reduced cell geometry.
4. The stent of claim 3, wherein the progressively reduced cell geometry has a progressive reduction of the cell size.
5. The stent of claim 1, wherein each expansion ring column has a horizontal column width and a circumferential diameter.
6. The stent of claim 1, wherein a circumferential diameter of all expansion ring columns have same dimension through out the entire longitudinal length of the stent.
7. The stent of claim 1, wherein a horizontal length of the expansion strut pair and a horizontal column width of the expansion ring column have identical dimensions in an expansion ring column.
8. The stent of claim 1, wherein a horizontal length of the expansion strut pairs and a horizontal column width of the expansion ring column have identical dimensions in each expansion ring column of plurality of expansion ring columns of the stent.
9. The stent of claim 1, wherein an expansion ring column at the proximal end of the stent has the widest horizontal column width.
10. The stent of claim 1, wherein an expansion ring column at the distal end of the stent has the narrowest horizontal column width.
11. The stent of claim 1, wherein each expansion ring column located between the proximal end and distal end of the stent has a progressively narrower horizontal column width.
12. The stent of claim 11, wherein a progressive narrowing of the horizontal column width of expansion ring columns have a constant rate of reduction.
13. The stent of claim 11, wherein a progressive narrowing of the horizontal column width of expansion ring columns have a variable rate of reduction.
14. The stent of claim 1, wherein the proximal end of the stent has the longest horizontal length of expansion strut pairs.
15. The stent of claim 1, wherein the distal end of the stent has the shortest horizontal length of expansion strut pairs.
16. The stent of claim 1, wherein each expansion ring column between the proximal end and distal end has progressively shorter horizontal length of expansion strut pairs.
17. The stent of claim 16, wherein a progressive shortening of a horizontal length of expansion strut pairs has a constant rate of reduction.
18. The stent of claim 16, wherein a progressive shortening of a horizontal length of expansion strut pairs has a variable rate of reduction.
19. The stent of claim 1, wherein the stent is delivered to a target vessel site mounted on a matching delivery catheter.
20. The stent of claim 1, wherein the stent is expanded in a vessel site with a matching tapered balloon.
21. Stent claim 20, wherein an optimally expanded tapered stent in a vessel has a similar tapering as a natural taper of the vessel lumen.
22. The stent of claim 1, wherein the tapering of the stent is at least in a portion of the stent.
23. The stent of claim 1, wherein the tapering of the stent is at least in a proximal portion of the stent.
24. The stent of claim 1, wherein the tapering of the stent is at least in a distal portion of the stent.
25. The stent of claim 1, wherein the tapering of the stent is at least in a middle portion of the stent.
26. The stent of claim 1, wherein the tapering of the stent includes all portions of the stent.
27. The stent of claim 1, wherein a tapered stent is a balloon expanded stent.
28. The stent of claim 1, wherein a tapered stent is a self-expanding stent.
29. The stent of claim 1, wherein a tapered stent is a partially self-expanding stent.
30. A tubular stent in unexpanded state configured to transform into a tapered tubular form when expanded and having a plurality of expansion columns and connector columns arranged along a longitudinal axis in a horizontal plane, comprising:
a plurality of expansion ring columns having expansion strut pairs, the plurality of expansion ring columns including an unbroken first expansion ring column made of a plurality of first expansion strut pairs each having a first expansion strut and an adjacent second expansion strut, and a second unbroken expansion ring column made of a plurality of second expansion strut pairs each having a first expansion strut and an adjacent second expansion strut, wherein expansion strut pairs of each expansion ring column of the plurality of expansion ring columns have geometric configurations similar to the first expansion ring column or the second expansion ring column, each unbroken expansion ring column having a progressively narrower horizontal width from a proximal to a distal end of the stent along the longitudinal axis of the stent and each unbroken expansion ring column having a same circumferential diameter, wherein expansion strut pairs in each unbroken expansion ring column have a progressively shorter length from one expansion ring column to a next ring column from the proximal end to the distal end of the stent.
a plurality of connector columns that couple adjacent expansion columns, the plurality of connector columns including a first connector column that couples the first expansion column to the second expansion column, wherein each connector column of the plurality of connector columns having at least a first connector strut, each first connector strut and connector column having a horizontal dimension and at least a portion of each first connector strut having a shaped configuration.
31. The stent of claim 30, wherein all connector columns have identical horizontal dimension.
32. The stent of claim 30, wherein all connector struts have identical horizontal dimension.
33. The stent of claim 30, wherein connector struts in the proximal end connector column has the longest horizontal dimension.
34. The stent of claim 30, wherein connector struts in the distal end connector column has the shortest horizontal dimension.
35. The stent of claim 30, wherein a connector column in the proximal end has the longest horizontal dimension.
36. The stent of claim 30, wherein a connector column in the distal end has the shortest horizontal dimension.
37. The stent of claim 30, wherein connector columns between the proximal end and distal end have a progressively longer horizontal dimension.
38. The stent of claim 30, wherein connector columns between the proximal end and distal end have a progressively shorter horizontal dimension.
39. The stent of claim 30, wherein connector struts in connector columns between the proximal end and distal end has a progressively longer horizontal dimension.
40. The stent of claim 30, wherein connector struts in connector columns between the proximal end and distal end has a progressively shorter horizontal dimension.
41. The stent of claim 30, wherein connector struts in at least some connector columns between the proximal end and distal end has a progressively longer horizontal dimension.
42. The stent of claim 30, wherein connector struts in at least some connector columns between the proximal end and distal end has a progressively shorter horizontal dimension.
43. The stent of claim 30, wherein connector struts in at least some connector columns in the proximal end of the stent has a progressively longer horizontal dimension.
44. The stent of claim 30, wherein connector struts in at least some connector columns in the proximal end of the stent has a progressively shorter horizontal dimension.
45. The stent of claim 30, wherein connector struts in at least some connector columns in the distal end of the stent has a progressively longer horizontal dimension.
46. The stent of claim 30, wherein connector struts in at least some connector columns in the distal end of the stent has a progressively shorter horizontal dimension.
47. The stent of claim 30, wherein connector struts in at least some connector columns in the middle of the stent has a progressively longer horizontal dimension.
48. The stent of claim 30, wherein connector struts in at least some connector columns in the middle of the stent has a progressively shorter horizontal dimension.
US10/123,889 1996-04-26 2002-04-15 Intravascular stent Abandoned US20020169500A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/123,889 US20020169500A1 (en) 1996-04-26 2002-04-15 Intravascular stent

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US1748496P 1996-04-26 1996-04-26
US7341298P 1998-02-02 1998-02-02
US09/237,537 US6235053B1 (en) 1998-02-02 1999-01-26 Tubular stent consists of chevron-shape expansion struts and contralaterally attached diagonal connectors
US09/839,287 US20010020183A1 (en) 1998-02-02 2001-04-20 Tubular stent consists of chevron-shape expansion struts and contralaterally attached diagonal-connectors
US09/839,442 US6409761B1 (en) 1996-04-26 2001-04-20 Intravascular stent
US10/123,889 US20020169500A1 (en) 1996-04-26 2002-04-15 Intravascular stent

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US09/839,287 Continuation US20010020183A1 (en) 1996-04-26 2001-04-20 Tubular stent consists of chevron-shape expansion struts and contralaterally attached diagonal-connectors
US09/839,442 Continuation US6409761B1 (en) 1996-04-26 2001-04-20 Intravascular stent

Publications (1)

Publication Number Publication Date
US20020169500A1 true US20020169500A1 (en) 2002-11-14

Family

ID=26689934

Family Applications (3)

Application Number Title Priority Date Filing Date
US08/824,866 Expired - Lifetime US5954743A (en) 1996-04-26 1997-03-25 Intravascular stent
US08/824,865 Expired - Lifetime US6152957A (en) 1996-04-26 1997-03-25 Intravascular stent
US10/123,889 Abandoned US20020169500A1 (en) 1996-04-26 2002-04-15 Intravascular stent

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US08/824,866 Expired - Lifetime US5954743A (en) 1996-04-26 1997-03-25 Intravascular stent
US08/824,865 Expired - Lifetime US6152957A (en) 1996-04-26 1997-03-25 Intravascular stent

Country Status (1)

Country Link
US (3) US5954743A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040267350A1 (en) * 2002-10-30 2004-12-30 Roubin Gary S. Non-foreshortening intraluminal prosthesis
US20070073376A1 (en) * 2005-08-22 2007-03-29 Krolik Jeffrey A Steep-taper flared stents and apparatus and methods for delivering them
US20070213808A1 (en) * 1997-02-07 2007-09-13 Endosystems Llc Non-foreshortening intraluminal prosthesis

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0759730B1 (en) 1994-05-19 1999-02-10 Scimed Life Systems, Inc. Improved tissue supporting devices
US7204848B1 (en) 1995-03-01 2007-04-17 Boston Scientific Scimed, Inc. Longitudinally flexible expandable stent
US6981986B1 (en) * 1995-03-01 2006-01-03 Boston Scientific Scimed, Inc. Longitudinally flexible expandable stent
CA2186029C (en) * 1995-03-01 2003-04-08 Brian J. Brown Improved longitudinally flexible expandable stent
US6896696B2 (en) 1998-11-20 2005-05-24 Scimed Life Systems, Inc. Flexible and expandable stent
JP4636634B2 (en) 1996-04-26 2011-02-23 ボストン サイエンティフィック サイムド,インコーポレイテッド Intravascular stent
US20040106985A1 (en) 1996-04-26 2004-06-03 Jang G. David Intravascular stent
US6235053B1 (en) 1998-02-02 2001-05-22 G. David Jang Tubular stent consists of chevron-shape expansion struts and contralaterally attached diagonal connectors
US6783543B2 (en) * 2000-06-05 2004-08-31 Scimed Life Systems, Inc. Intravascular stent with increasing coating retaining capacity
US5954743A (en) * 1996-04-26 1999-09-21 Jang; G. David Intravascular stent
US5807404A (en) * 1996-09-19 1998-09-15 Medinol Ltd. Stent with variable features to optimize support and method of making such stent
US20060173531A1 (en) * 1996-09-19 2006-08-03 Jacob Richter Stent with variable features to optimize support and method of making such stent
US7208010B2 (en) * 2000-10-16 2007-04-24 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US6241762B1 (en) * 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US6261319B1 (en) * 1998-07-08 2001-07-17 Scimed Life Systems, Inc. Stent
US6461380B1 (en) 1998-07-28 2002-10-08 Advanced Cardiovascular Systems, Inc. Stent configuration
US7815763B2 (en) 2001-09-28 2010-10-19 Abbott Laboratories Vascular Enterprises Limited Porous membranes for medical implants and methods of manufacture
US6682554B2 (en) 1998-09-05 2004-01-27 Jomed Gmbh Methods and apparatus for a stent having an expandable web structure
US6755856B2 (en) 1998-09-05 2004-06-29 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation
US7887578B2 (en) 1998-09-05 2011-02-15 Abbott Laboratories Vascular Enterprises Limited Stent having an expandable web structure
US6193744B1 (en) * 1998-09-10 2001-02-27 Scimed Life Systems, Inc. Stent configurations
US8092514B1 (en) * 1998-11-16 2012-01-10 Boston Scientific Scimed, Inc. Stretchable anti-buckling coiled-sheet stent
US6660030B2 (en) 1998-12-11 2003-12-09 Endologix, Inc. Bifurcation graft deployment catheter
US6317615B1 (en) 1999-04-19 2001-11-13 Cardiac Pacemakers, Inc. Method and system for reducing arterial restenosis in the presence of an intravascular stent
US6273911B1 (en) 1999-04-22 2001-08-14 Advanced Cardiovascular Systems, Inc. Variable strength stent
EP1554993B1 (en) * 1999-07-02 2012-08-01 Endotex Interventional Systems, Inc. Flexible, stretchable coiled-sheet stent
US6524381B1 (en) * 2000-03-31 2003-02-25 Flex Products, Inc. Methods for producing enhanced interference pigments
EP1132058A1 (en) * 2000-03-06 2001-09-12 Advanced Laser Applications Holding S.A. Intravascular prothesis
US6616689B1 (en) 2000-05-03 2003-09-09 Advanced Cardiovascular Systems, Inc. Intravascular stent
AU6539101A (en) 2000-06-05 2001-12-17 G David Jang Intravascular stent with increasing coating retaining capacity
US6652576B1 (en) 2000-06-07 2003-11-25 Advanced Cardiovascular Systems, Inc. Variable stiffness stent
US7632303B1 (en) 2000-06-07 2009-12-15 Advanced Cardiovascular Systems, Inc. Variable stiffness medical devices
US8070792B2 (en) 2000-09-22 2011-12-06 Boston Scientific Scimed, Inc. Stent
US7766956B2 (en) 2000-09-22 2010-08-03 Boston Scientific Scimed, Inc. Intravascular stent and assembly
US6685679B2 (en) * 2000-12-06 2004-02-03 Scimed Life Systems, Inc. Interlocking metal shaft
US6929660B1 (en) 2000-12-22 2005-08-16 Advanced Cardiovascular Systems, Inc. Intravascular stent
ATE449579T1 (en) 2001-01-15 2009-12-15 Terumo Corp STENT
US6679911B2 (en) 2001-03-01 2004-01-20 Cordis Corporation Flexible stent
US6998060B2 (en) * 2001-03-01 2006-02-14 Cordis Corporation Flexible stent and method of manufacture
WO2002071975A2 (en) * 2001-03-13 2002-09-19 Yoram Richter Method and apparatus for stenting
US6749628B1 (en) 2001-05-17 2004-06-15 Advanced Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcations
US6629994B2 (en) * 2001-06-11 2003-10-07 Advanced Cardiovascular Systems, Inc. Intravascular stent
US6939373B2 (en) * 2003-08-20 2005-09-06 Advanced Cardiovascular Systems, Inc. Intravascular stent
US6818013B2 (en) * 2001-06-14 2004-11-16 Cordis Corporation Intravascular stent device
US6673106B2 (en) * 2001-06-14 2004-01-06 Cordis Neurovascular, Inc. Intravascular stent device
US6635083B1 (en) 2001-06-25 2003-10-21 Advanced Cardiovascular Systems, Inc. Stent with non-linear links and method of use
US6749629B1 (en) 2001-06-27 2004-06-15 Advanced Cardiovascular Systems, Inc. Stent pattern with figure-eights
US7842083B2 (en) 2001-08-20 2010-11-30 Innovational Holdings, Llc. Expandable medical device with improved spatial distribution
IES20010828A2 (en) * 2001-09-12 2003-03-19 Medtronic Inc Medical device for intraluminal endovascular stenting
EP1516600B1 (en) * 2001-09-18 2007-03-14 Abbott Laboratories Vascular Enterprises Limited Stent
US7060089B2 (en) * 2002-01-23 2006-06-13 Boston Scientific Scimed, Inc. Multi-layer stent
US7195648B2 (en) 2002-05-16 2007-03-27 Cordis Neurovascular, Inc. Intravascular stent device
US6656220B1 (en) 2002-06-17 2003-12-02 Advanced Cardiovascular Systems, Inc. Intravascular stent
DE10233085B4 (en) 2002-07-19 2014-02-20 Dendron Gmbh Stent with guide wire
US8425549B2 (en) 2002-07-23 2013-04-23 Reverse Medical Corporation Systems and methods for removing obstructive matter from body lumens and treating vascular defects
US7185034B2 (en) * 2002-08-01 2007-02-27 Oracle International Corporation Buffered message queue architecture for database management systems with guaranteed at least once delivery
US6945995B2 (en) * 2002-08-29 2005-09-20 Boston Scientific Scimed, Inc. Stent overlap point markers
US7179286B2 (en) 2003-02-21 2007-02-20 Boston Scientific Scimed, Inc. Stent with stepped connectors
US6916336B2 (en) * 2003-06-09 2005-07-12 Avantec Vascular Corporation Vascular prosthesis
US7491227B2 (en) * 2003-06-16 2009-02-17 Boston Scientific Scimed, Inc. Coiled-sheet stent with flexible mesh design
US7959665B2 (en) * 2003-07-31 2011-06-14 Abbott Cardiovascular Systems Inc. Intravascular stent with inverted end rings
US20050060025A1 (en) * 2003-09-12 2005-03-17 Mackiewicz David A. Radiopaque markers for medical devices
US20060074480A1 (en) 2004-09-01 2006-04-06 Pst, Llc Stent and method for manufacturing the stent
CA2598164C (en) * 2004-12-08 2013-10-08 Innovational Holdings Llc Expandable medical device with differential hinge performance
CA2610108C (en) * 2005-04-04 2014-03-25 Burpee Materials Technology, Llc Flexible stent
US7763198B2 (en) 2005-04-12 2010-07-27 Abbott Cardiovascular Systems Inc. Method for retaining a vascular stent on a catheter
US7947207B2 (en) 2005-04-12 2011-05-24 Abbott Cardiovascular Systems Inc. Method for retaining a vascular stent on a catheter
US20060248698A1 (en) * 2005-05-05 2006-11-09 Hanson Brian J Tubular stent and methods of making the same
US8956400B2 (en) * 2005-10-14 2015-02-17 Flexible Stenting Solutions, Inc. Helical stent
WO2007095466A2 (en) 2006-02-14 2007-08-23 Angiomed Gmbh & Co. Medizintechnik Kg Highly flexible stent and method of manufacture
US20070191926A1 (en) * 2006-02-14 2007-08-16 Advanced Cardiovascular Systems, Inc. Stent pattern for high stent retention
US8029558B2 (en) 2006-07-07 2011-10-04 Abbott Cardiovascular Systems, Inc. Stent and catheter assembly and method for treating bifurcations
US7988720B2 (en) 2006-09-12 2011-08-02 Boston Scientific Scimed, Inc. Longitudinally flexible expandable stent
US8778009B2 (en) 2006-10-06 2014-07-15 Abbott Cardiovascular Systems Inc. Intravascular stent
US20080269774A1 (en) 2006-10-26 2008-10-30 Chestnut Medical Technologies, Inc. Intracorporeal Grasping Device
US8128679B2 (en) 2007-05-23 2012-03-06 Abbott Laboratories Vascular Enterprises Limited Flexible stent with torque-absorbing connectors
US8016874B2 (en) 2007-05-23 2011-09-13 Abbott Laboratories Vascular Enterprises Limited Flexible stent with elevated scaffolding properties
US7988723B2 (en) 2007-08-02 2011-08-02 Flexible Stenting Solutions, Inc. Flexible stent
US11337714B2 (en) 2007-10-17 2022-05-24 Covidien Lp Restoring blood flow and clot removal during acute ischemic stroke
US8088140B2 (en) 2008-05-19 2012-01-03 Mindframe, Inc. Blood flow restorative and embolus removal methods
US7972373B2 (en) * 2007-12-19 2011-07-05 Advanced Technologies And Regenerative Medicine, Llc Balloon expandable bioabsorbable stent with a single stress concentration region interconnecting adjacent struts
US8337544B2 (en) 2007-12-20 2012-12-25 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having flexible connectors
US8920488B2 (en) 2007-12-20 2014-12-30 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having a stable architecture
US7850726B2 (en) 2007-12-20 2010-12-14 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having struts linked by foot extensions
AU2009217354B2 (en) 2008-02-22 2013-10-10 Covidien Lp Methods and apparatus for flow restoration
US8104835B2 (en) * 2008-07-08 2012-01-31 Invacare Corp. Standing frame with supine mode
US9149376B2 (en) 2008-10-06 2015-10-06 Cordis Corporation Reconstrainable stent delivery system
EP2421470A4 (en) * 2009-04-24 2016-03-30 Flexible Stenting Solutions Inc Flexible devices
WO2011017123A2 (en) 2009-07-27 2011-02-10 Endologix, Inc. Stent graft
US9649211B2 (en) 2009-11-04 2017-05-16 Confluent Medical Technologies, Inc. Alternating circumferential bridge stent design and methods for use thereof
US10092427B2 (en) 2009-11-04 2018-10-09 Confluent Medical Technologies, Inc. Alternating circumferential bridge stent design and methods for use thereof
US8864811B2 (en) 2010-06-08 2014-10-21 Veniti, Inc. Bi-directional stent delivery system
US9301864B2 (en) 2010-06-08 2016-04-05 Veniti, Inc. Bi-directional stent delivery system
US9233014B2 (en) 2010-09-24 2016-01-12 Veniti, Inc. Stent with support braces
US9039749B2 (en) 2010-10-01 2015-05-26 Covidien Lp Methods and apparatuses for flow restoration and implanting members in the human body
EP2658484A1 (en) 2010-12-30 2013-11-06 Boston Scientific Scimed, Inc. Multi stage opening stent designs
WO2012119037A1 (en) 2011-03-03 2012-09-07 Boston Scientific Scimed, Inc. Stent with reduced profile
JP2014511247A (en) 2011-03-03 2014-05-15 ボストン サイエンティフィック サイムド,インコーポレイテッド Low strain high strength stent
US8998977B2 (en) 2012-04-13 2015-04-07 Medtronic Vascular, Inc. Hollow drug-filled stent and method of forming hollow drug-filled stent
US10076399B2 (en) 2013-09-13 2018-09-18 Covidien Lp Endovascular device engagement
EP3119354B1 (en) 2014-03-18 2018-06-06 Boston Scientific Scimed, Inc. Reduced granulation and inflammation stent design
US10238513B2 (en) 2017-07-19 2019-03-26 Abbott Cardiovascular Systems Inc. Intravascular stent

Citations (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US335341A (en) * 1886-02-02 Spring-rail frog for railways
US617868A (en) * 1899-01-17 Carl troeger
US2836181A (en) * 1955-01-17 1958-05-27 Chemstrand Corp Flexible nylon tube and method for preparing same
US3015492A (en) * 1960-04-05 1962-01-02 St Lawrence Mfg Company Inc Collapsible ice skate scabbard
US3490975A (en) * 1965-10-18 1970-01-20 Univ Of Birmingham The Method of making an artificial artery of wound silicone rubber thread
US3509883A (en) * 1967-11-29 1970-05-05 Gen Electric Expanding cannula
US3562820A (en) * 1966-08-22 1971-02-16 Bernhard Braun Tubular sheet and strip form prostheses on a basis of biological tissue
US3635215A (en) * 1969-08-14 1972-01-18 Gam Rad Medical removal hook
US3868956A (en) * 1972-06-05 1975-03-04 Ralph J Alfidi Vessel implantable appliance and method of implanting it
US4078167A (en) * 1977-02-09 1978-03-07 United Technologies Corporation Welding shield and plasma suppressor apparatus
US4140126A (en) * 1977-02-18 1979-02-20 Choudhury M Hasan Method for performing aneurysm repair
US4141364A (en) * 1977-03-18 1979-02-27 Jorge Schultze Expandable endotracheal or urethral tube
US4313231A (en) * 1980-06-16 1982-02-02 Kabushiki Kaisha Tatebe Seishudo Vascular prosthesis
US4319363A (en) * 1978-05-23 1982-03-16 Vettivetpillai Ketharanathan Vascular prostheses
US4425908A (en) * 1981-10-22 1984-01-17 Beth Israel Hospital Blood clot filter
US4441215A (en) * 1980-11-17 1984-04-10 Kaster Robert L Vascular graft
US4501264A (en) * 1978-06-02 1985-02-26 Rockey Arthur G Medical sleeve
US4503569A (en) * 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
US4512338A (en) * 1983-01-25 1985-04-23 Balko Alexander B Process for restoring patency to body vessels
US4580568A (en) * 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US4647416A (en) * 1983-08-03 1987-03-03 Shiley Incorporated Method of preparing a vascular graft prosthesis
US4649922A (en) * 1986-01-23 1987-03-17 Wiktor Donimik M Catheter arrangement having a variable diameter tip and spring prosthesis
US4655776A (en) * 1984-01-12 1987-04-07 Oto Enterprises, Inc. Prostheses for ossicular reconstruction
US4655771A (en) * 1982-04-30 1987-04-07 Shepherd Patents S.A. Prosthesis comprising an expansible or contractile tubular body
US4665918A (en) * 1986-01-06 1987-05-19 Garza Gilbert A Prosthesis system and method
US4733665A (en) * 1985-11-07 1988-03-29 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4740207A (en) * 1986-09-10 1988-04-26 Kreamer Jeffry W Intralumenal graft
US4795465A (en) * 1987-05-14 1989-01-03 Hood Laboratories Tracheobronchial stent
US4795458A (en) * 1987-07-02 1989-01-03 Regan Barrie F Stent for use following balloon angioplasty
US4800882A (en) * 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US4820298A (en) * 1987-11-20 1989-04-11 Leveen Eric G Internal vascular prosthesis
US4830003A (en) * 1988-06-17 1989-05-16 Wolff Rodney G Compressive stent and delivery system
US4913141A (en) * 1988-10-25 1990-04-03 Cordis Corporation Apparatus and method for placement of a stent within a subject vessel
US4922905A (en) * 1985-11-30 1990-05-08 Strecker Ernst P Dilatation catheter
US4994071A (en) * 1989-05-22 1991-02-19 Cordis Corporation Bifurcating stent apparatus and method
US5015253A (en) * 1989-06-15 1991-05-14 Cordis Corporation Non-woven endoprosthesis
US5019090A (en) * 1988-09-01 1991-05-28 Corvita Corporation Radially expandable endoprosthesis and the like
US5092877A (en) * 1988-09-01 1992-03-03 Corvita Corporation Radially expandable endoprosthesis
US5102417A (en) * 1985-11-07 1992-04-07 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US5104399A (en) * 1986-12-10 1992-04-14 Endovascular Technologies, Inc. Artificial graft and implantation method
US5104404A (en) * 1989-10-02 1992-04-14 Medtronic, Inc. Articulated stent
US5108417A (en) * 1990-09-14 1992-04-28 Interface Biomedical Laboratories Corp. Anti-turbulent, anti-thrombogenic intravascular stent
US5195984A (en) * 1988-10-04 1993-03-23 Expandable Grafts Partnership Expandable intraluminal graft
US5197978A (en) * 1991-04-26 1993-03-30 Advanced Coronary Technology, Inc. Removable heat-recoverable tissue supporting device
US5282823A (en) * 1992-03-19 1994-02-01 Medtronic, Inc. Intravascular radially expandable stent
US5282824A (en) * 1990-10-09 1994-02-01 Cook, Incorporated Percutaneous stent assembly
US5292331A (en) * 1989-08-24 1994-03-08 Applied Vascular Engineering, Inc. Endovascular support device
US5304200A (en) * 1991-05-29 1994-04-19 Cordis Corporation Welded radially expandable endoprosthesis and the like
US5312430A (en) * 1986-12-09 1994-05-17 Rosenbluth Robert F Balloon dilation catheter
US5314472A (en) * 1991-10-01 1994-05-24 Cook Incorporated Vascular stent
US5383892A (en) * 1991-11-08 1995-01-24 Meadox France Stent for transluminal implantation
US5389106A (en) * 1993-10-29 1995-02-14 Numed, Inc. Impermeable expandable intravascular stent
US5405377A (en) * 1992-02-21 1995-04-11 Endotech Ltd. Intraluminal stent
US5507767A (en) * 1992-01-15 1996-04-16 Cook Incorporated Spiral stent
US5591197A (en) * 1995-03-14 1997-01-07 Advanced Cardiovascular Systems, Inc. Expandable stent forming projecting barbs and method for deploying
US5593442A (en) * 1995-06-05 1997-01-14 Localmed, Inc. Radially expansible and articulated vessel scaffold
US5613981A (en) * 1995-04-21 1997-03-25 Medtronic, Inc. Bidirectional dual sinusoidal helix stent
US5707386A (en) * 1993-02-04 1998-01-13 Angiomed Gmbh & Company Medizintechnik Kg Stent and method of making a stent
US5713949A (en) * 1996-08-06 1998-02-03 Jayaraman; Swaminathan Microporous covered stents and method of coating
US5718713A (en) * 1997-04-10 1998-02-17 Global Therapeutics, Inc. Surgical stent having a streamlined contour
US5733303A (en) * 1994-03-17 1998-03-31 Medinol Ltd. Flexible expandable stent
US5733301A (en) * 1996-01-11 1998-03-31 Schneider (Usa) Inc. Laser ablation of angioplasty catheters and balloons
US5735893A (en) * 1991-10-28 1998-04-07 Advanced Cardiovascular Systems, Inc. Expandable stents and method for making same
US5735871A (en) * 1994-12-09 1998-04-07 Sgro; Jean-Claude Self-expanding endoprosthesis
US5741327A (en) * 1997-05-06 1998-04-21 Global Therapeutics, Inc. Surgical stent featuring radiopaque markers
US5861027A (en) * 1996-04-10 1999-01-19 Variomed Ag Stent for the transluminal implantation in hollow organs
US5876449A (en) * 1995-04-01 1999-03-02 Variomed Ag Stent for the transluminal implantation in hollow organs
US5879370A (en) * 1994-02-25 1999-03-09 Fischell; Robert E. Stent having a multiplicity of undulating longitudinals
US5895406A (en) * 1996-01-26 1999-04-20 Cordis Corporation Axially flexible stent
US5897588A (en) * 1997-03-14 1999-04-27 Hull; Cheryl C. Coronary stent and method of fabricating same
US6010530A (en) * 1995-06-07 2000-01-04 Boston Scientific Technology, Inc. Self-expanding endoluminal prosthesis
US6033433A (en) * 1997-04-25 2000-03-07 Scimed Life Systems, Inc. Stent configurations including spirals
US6039756A (en) * 1996-04-26 2000-03-21 Jang; G. David Intravascular stent
US6042606A (en) * 1997-09-29 2000-03-28 Cook Incorporated Radially expandable non-axially contracting surgical stent
US6053940A (en) * 1995-10-20 2000-04-25 Wijay; Bandula Vascular stent
US6183506B1 (en) * 1996-03-05 2001-02-06 Divysio Solutions Ltd. Expandable stent and method for delivery of same
US6190404B1 (en) * 1997-11-07 2001-02-20 Advanced Bio Prosthetic Surfaces, Ltd. Intravascular stent and method for manufacturing an intravascular stent
US6190403B1 (en) * 1998-11-13 2001-02-20 Cordis Corporation Low profile radiopaque stent with increased longitudinal flexibility and radial rigidity
US6190406B1 (en) * 1998-01-09 2001-02-20 Nitinal Development Corporation Intravascular stent having tapered struts
US6193747B1 (en) * 1997-02-17 2001-02-27 Jomed Implantate Gmbh Stent
US6193744B1 (en) * 1998-09-10 2001-02-27 Scimed Life Systems, Inc. Stent configurations
US6200334B1 (en) * 1998-02-03 2001-03-13 G. David Jang Tubular stent consists of non-parallel expansion struts and contralaterally attached diagonal connectors
US6200337B1 (en) * 1996-03-10 2001-03-13 Terumo Kabushiki Kaisha Implanting stent
US6203569B1 (en) * 1996-01-04 2001-03-20 Bandula Wijay Flexible stent
US6206916B1 (en) * 1998-04-15 2001-03-27 Joseph G. Furst Coated intraluminal graft
US6206911B1 (en) * 1996-12-19 2001-03-27 Simcha Milo Stent combination
US6206915B1 (en) * 1998-09-29 2001-03-27 Medtronic Ave, Inc. Drug storing and metering stent
US6348065B1 (en) * 1995-03-01 2002-02-19 Scimed Life Systems, Inc. Longitudinally flexible expandable stent
US6355059B1 (en) * 1998-12-03 2002-03-12 Medinol, Ltd. Serpentine coiled ladder stent
US20020038145A1 (en) * 2000-06-05 2002-03-28 Jang G. David Intravascular stent with increasing coating retaining capacity
US20020042647A1 (en) * 2000-09-22 2002-04-11 Jang G. David Intravascular stent apparatus
US20020045933A1 (en) * 2000-09-25 2002-04-18 Jang G. David Intravascular stent apparatus
US20020045934A1 (en) * 2000-09-25 2002-04-18 Jang G. David Intravascular stent apparatus
US20020045935A1 (en) * 2000-09-23 2002-04-18 Jang G. David Intravascular stent apparatus
US20020049493A1 (en) * 1996-04-26 2002-04-25 Jang G. David Intravascular stent
US6379381B1 (en) * 1999-09-03 2002-04-30 Advanced Cardiovascular Systems, Inc. Porous prosthesis and a method of depositing substances into the pores
US20030028242A1 (en) * 2001-07-20 2003-02-06 Franco Vallana Angioplasty stents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE9014230U1 (en) * 1990-10-13 1991-11-21 Angiomed Ag, 7500 Karlsruhe, De
US5540712A (en) * 1992-05-01 1996-07-30 Nitinol Medical Technologies, Inc. Stent and method and apparatus for forming and delivering the same
US5449373A (en) * 1994-03-17 1995-09-12 Medinol Ltd. Articulated stent
EP0679372B1 (en) * 1994-04-25 1999-07-28 Advanced Cardiovascular Systems, Inc. Radiopaque stent markers
US5545210A (en) * 1994-09-22 1996-08-13 Advanced Coronary Technology, Inc. Method of implanting a permanent shape memory alloy stent
IL115756A0 (en) * 1994-10-27 1996-01-19 Medinol Ltd Stent fabrication method
US5695516A (en) * 1996-02-21 1997-12-09 Iso Stent, Inc. Longitudinally elongating balloon expandable stent
US5954743A (en) * 1996-04-26 1999-09-21 Jang; G. David Intravascular stent
US5922021A (en) * 1996-04-26 1999-07-13 Jang; G. David Intravascular stent
DE29608037U1 (en) * 1996-05-03 1996-07-11 Sitomed Gmbh Coronary stent
US5948016A (en) * 1997-09-25 1999-09-07 Jang; G. David Intravascular stent with non-parallel slots

Patent Citations (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US335341A (en) * 1886-02-02 Spring-rail frog for railways
US617868A (en) * 1899-01-17 Carl troeger
US2836181A (en) * 1955-01-17 1958-05-27 Chemstrand Corp Flexible nylon tube and method for preparing same
US3015492A (en) * 1960-04-05 1962-01-02 St Lawrence Mfg Company Inc Collapsible ice skate scabbard
US3490975A (en) * 1965-10-18 1970-01-20 Univ Of Birmingham The Method of making an artificial artery of wound silicone rubber thread
US3562820A (en) * 1966-08-22 1971-02-16 Bernhard Braun Tubular sheet and strip form prostheses on a basis of biological tissue
US3509883A (en) * 1967-11-29 1970-05-05 Gen Electric Expanding cannula
US3635215A (en) * 1969-08-14 1972-01-18 Gam Rad Medical removal hook
US3868956A (en) * 1972-06-05 1975-03-04 Ralph J Alfidi Vessel implantable appliance and method of implanting it
US4078167A (en) * 1977-02-09 1978-03-07 United Technologies Corporation Welding shield and plasma suppressor apparatus
US4140126A (en) * 1977-02-18 1979-02-20 Choudhury M Hasan Method for performing aneurysm repair
US4141364A (en) * 1977-03-18 1979-02-27 Jorge Schultze Expandable endotracheal or urethral tube
US4319363A (en) * 1978-05-23 1982-03-16 Vettivetpillai Ketharanathan Vascular prostheses
US4501264A (en) * 1978-06-02 1985-02-26 Rockey Arthur G Medical sleeve
US4313231A (en) * 1980-06-16 1982-02-02 Kabushiki Kaisha Tatebe Seishudo Vascular prosthesis
US4441215A (en) * 1980-11-17 1984-04-10 Kaster Robert L Vascular graft
US4425908A (en) * 1981-10-22 1984-01-17 Beth Israel Hospital Blood clot filter
US4655771A (en) * 1982-04-30 1987-04-07 Shepherd Patents S.A. Prosthesis comprising an expansible or contractile tubular body
US4655771B1 (en) * 1982-04-30 1996-09-10 Medinvent Ams Sa Prosthesis comprising an expansible or contractile tubular body
US4512338A (en) * 1983-01-25 1985-04-23 Balko Alexander B Process for restoring patency to body vessels
US4503569A (en) * 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
US4647416A (en) * 1983-08-03 1987-03-03 Shiley Incorporated Method of preparing a vascular graft prosthesis
US4655776A (en) * 1984-01-12 1987-04-07 Oto Enterprises, Inc. Prostheses for ossicular reconstruction
US4580568A (en) * 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US4733665B1 (en) * 1985-11-07 1994-01-11 Expandable Grafts Partnership Expandable intraluminal graft,and method and apparatus for implanting an expandable intraluminal graft
US4733665A (en) * 1985-11-07 1988-03-29 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4739762A (en) * 1985-11-07 1988-04-26 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US5102417A (en) * 1985-11-07 1992-04-07 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4739762B1 (en) * 1985-11-07 1998-10-27 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4733665C2 (en) * 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4922905A (en) * 1985-11-30 1990-05-08 Strecker Ernst P Dilatation catheter
US4665918A (en) * 1986-01-06 1987-05-19 Garza Gilbert A Prosthesis system and method
US4649922A (en) * 1986-01-23 1987-03-17 Wiktor Donimik M Catheter arrangement having a variable diameter tip and spring prosthesis
US4740207A (en) * 1986-09-10 1988-04-26 Kreamer Jeffry W Intralumenal graft
US5312430A (en) * 1986-12-09 1994-05-17 Rosenbluth Robert F Balloon dilation catheter
US5104399A (en) * 1986-12-10 1992-04-14 Endovascular Technologies, Inc. Artificial graft and implantation method
US4800882A (en) * 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US4795465A (en) * 1987-05-14 1989-01-03 Hood Laboratories Tracheobronchial stent
US4795458A (en) * 1987-07-02 1989-01-03 Regan Barrie F Stent for use following balloon angioplasty
US4820298A (en) * 1987-11-20 1989-04-11 Leveen Eric G Internal vascular prosthesis
US4830003A (en) * 1988-06-17 1989-05-16 Wolff Rodney G Compressive stent and delivery system
US5092877A (en) * 1988-09-01 1992-03-03 Corvita Corporation Radially expandable endoprosthesis
US5019090A (en) * 1988-09-01 1991-05-28 Corvita Corporation Radially expandable endoprosthesis and the like
US5195984A (en) * 1988-10-04 1993-03-23 Expandable Grafts Partnership Expandable intraluminal graft
US4913141A (en) * 1988-10-25 1990-04-03 Cordis Corporation Apparatus and method for placement of a stent within a subject vessel
US4994071A (en) * 1989-05-22 1991-02-19 Cordis Corporation Bifurcating stent apparatus and method
US5015253A (en) * 1989-06-15 1991-05-14 Cordis Corporation Non-woven endoprosthesis
US5292331A (en) * 1989-08-24 1994-03-08 Applied Vascular Engineering, Inc. Endovascular support device
US5104404A (en) * 1989-10-02 1992-04-14 Medtronic, Inc. Articulated stent
US5108417A (en) * 1990-09-14 1992-04-28 Interface Biomedical Laboratories Corp. Anti-turbulent, anti-thrombogenic intravascular stent
US5282824A (en) * 1990-10-09 1994-02-01 Cook, Incorporated Percutaneous stent assembly
US5197978A (en) * 1991-04-26 1993-03-30 Advanced Coronary Technology, Inc. Removable heat-recoverable tissue supporting device
US5197978B1 (en) * 1991-04-26 1996-05-28 Advanced Coronary Tech Removable heat-recoverable tissue supporting device
US5304200A (en) * 1991-05-29 1994-04-19 Cordis Corporation Welded radially expandable endoprosthesis and the like
US5314472A (en) * 1991-10-01 1994-05-24 Cook Incorporated Vascular stent
US5735893A (en) * 1991-10-28 1998-04-07 Advanced Cardiovascular Systems, Inc. Expandable stents and method for making same
US5383892A (en) * 1991-11-08 1995-01-24 Meadox France Stent for transluminal implantation
US5507767A (en) * 1992-01-15 1996-04-16 Cook Incorporated Spiral stent
US5405377A (en) * 1992-02-21 1995-04-11 Endotech Ltd. Intraluminal stent
US5282823A (en) * 1992-03-19 1994-02-01 Medtronic, Inc. Intravascular radially expandable stent
US5707386A (en) * 1993-02-04 1998-01-13 Angiomed Gmbh & Company Medizintechnik Kg Stent and method of making a stent
US5389106A (en) * 1993-10-29 1995-02-14 Numed, Inc. Impermeable expandable intravascular stent
US5879370A (en) * 1994-02-25 1999-03-09 Fischell; Robert E. Stent having a multiplicity of undulating longitudinals
US5733303A (en) * 1994-03-17 1998-03-31 Medinol Ltd. Flexible expandable stent
US5735871A (en) * 1994-12-09 1998-04-07 Sgro; Jean-Claude Self-expanding endoprosthesis
US6348065B1 (en) * 1995-03-01 2002-02-19 Scimed Life Systems, Inc. Longitudinally flexible expandable stent
US5591197A (en) * 1995-03-14 1997-01-07 Advanced Cardiovascular Systems, Inc. Expandable stent forming projecting barbs and method for deploying
US5876449A (en) * 1995-04-01 1999-03-02 Variomed Ag Stent for the transluminal implantation in hollow organs
US5613981A (en) * 1995-04-21 1997-03-25 Medtronic, Inc. Bidirectional dual sinusoidal helix stent
US5593442A (en) * 1995-06-05 1997-01-14 Localmed, Inc. Radially expansible and articulated vessel scaffold
US6010530A (en) * 1995-06-07 2000-01-04 Boston Scientific Technology, Inc. Self-expanding endoluminal prosthesis
US6053940A (en) * 1995-10-20 2000-04-25 Wijay; Bandula Vascular stent
US6203569B1 (en) * 1996-01-04 2001-03-20 Bandula Wijay Flexible stent
US5733301A (en) * 1996-01-11 1998-03-31 Schneider (Usa) Inc. Laser ablation of angioplasty catheters and balloons
US5895406A (en) * 1996-01-26 1999-04-20 Cordis Corporation Axially flexible stent
US6217608B1 (en) * 1996-03-05 2001-04-17 Divysio Solutions Ulc Expandable stent and method for delivery of same
US6183506B1 (en) * 1996-03-05 2001-02-06 Divysio Solutions Ltd. Expandable stent and method for delivery of same
US6200337B1 (en) * 1996-03-10 2001-03-13 Terumo Kabushiki Kaisha Implanting stent
US5861027A (en) * 1996-04-10 1999-01-19 Variomed Ag Stent for the transluminal implantation in hollow organs
US20020049493A1 (en) * 1996-04-26 2002-04-25 Jang G. David Intravascular stent
US6039756A (en) * 1996-04-26 2000-03-21 Jang; G. David Intravascular stent
US5713949A (en) * 1996-08-06 1998-02-03 Jayaraman; Swaminathan Microporous covered stents and method of coating
US6206911B1 (en) * 1996-12-19 2001-03-27 Simcha Milo Stent combination
US6193747B1 (en) * 1997-02-17 2001-02-27 Jomed Implantate Gmbh Stent
US5897588A (en) * 1997-03-14 1999-04-27 Hull; Cheryl C. Coronary stent and method of fabricating same
US5718713A (en) * 1997-04-10 1998-02-17 Global Therapeutics, Inc. Surgical stent having a streamlined contour
US6033433A (en) * 1997-04-25 2000-03-07 Scimed Life Systems, Inc. Stent configurations including spirals
US5741327A (en) * 1997-05-06 1998-04-21 Global Therapeutics, Inc. Surgical stent featuring radiopaque markers
US6042606A (en) * 1997-09-29 2000-03-28 Cook Incorporated Radially expandable non-axially contracting surgical stent
US6190404B1 (en) * 1997-11-07 2001-02-20 Advanced Bio Prosthetic Surfaces, Ltd. Intravascular stent and method for manufacturing an intravascular stent
US6190406B1 (en) * 1998-01-09 2001-02-20 Nitinal Development Corporation Intravascular stent having tapered struts
US6200334B1 (en) * 1998-02-03 2001-03-13 G. David Jang Tubular stent consists of non-parallel expansion struts and contralaterally attached diagonal connectors
US6206916B1 (en) * 1998-04-15 2001-03-27 Joseph G. Furst Coated intraluminal graft
US6193744B1 (en) * 1998-09-10 2001-02-27 Scimed Life Systems, Inc. Stent configurations
US6206915B1 (en) * 1998-09-29 2001-03-27 Medtronic Ave, Inc. Drug storing and metering stent
US6190403B1 (en) * 1998-11-13 2001-02-20 Cordis Corporation Low profile radiopaque stent with increased longitudinal flexibility and radial rigidity
US6355059B1 (en) * 1998-12-03 2002-03-12 Medinol, Ltd. Serpentine coiled ladder stent
US6379381B1 (en) * 1999-09-03 2002-04-30 Advanced Cardiovascular Systems, Inc. Porous prosthesis and a method of depositing substances into the pores
US20020038145A1 (en) * 2000-06-05 2002-03-28 Jang G. David Intravascular stent with increasing coating retaining capacity
US20020042647A1 (en) * 2000-09-22 2002-04-11 Jang G. David Intravascular stent apparatus
US20020045935A1 (en) * 2000-09-23 2002-04-18 Jang G. David Intravascular stent apparatus
US20020045934A1 (en) * 2000-09-25 2002-04-18 Jang G. David Intravascular stent apparatus
US20020045933A1 (en) * 2000-09-25 2002-04-18 Jang G. David Intravascular stent apparatus
US20030028242A1 (en) * 2001-07-20 2003-02-06 Franco Vallana Angioplasty stents

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070213808A1 (en) * 1997-02-07 2007-09-13 Endosystems Llc Non-foreshortening intraluminal prosthesis
US20070213806A1 (en) * 1997-02-07 2007-09-13 Endosystems Llc Non-foreshortening intraluminal prosthesis
US20070213807A1 (en) * 1997-02-07 2007-09-13 Endosystems Llc Non-foreshortening intraluminal prosthesis
US8882823B2 (en) 1997-02-07 2014-11-11 Endosystems Llc Non-foreshortening intraluminal prosthesis
US20040267350A1 (en) * 2002-10-30 2004-12-30 Roubin Gary S. Non-foreshortening intraluminal prosthesis
US20070073376A1 (en) * 2005-08-22 2007-03-29 Krolik Jeffrey A Steep-taper flared stents and apparatus and methods for delivering them
US8702777B2 (en) * 2005-08-22 2014-04-22 Incept, Llc Steep-taper flared stents and apparatus and methods for delivering them

Also Published As

Publication number Publication date
US6152957A (en) 2000-11-28
US5954743A (en) 1999-09-21

Similar Documents

Publication Publication Date Title
US7081130B2 (en) Intravascular Stent
US5954743A (en) Intravascular stent
US9078778B2 (en) Intravascular stent
US5922021A (en) Intravascular stent
CA2252596C (en) Intravascular stent
EP0971644A1 (en) Intravascular stent
WO1998048735A1 (en) Intravascular stent

Legal Events

Date Code Title Description
AS Assignment

Owner name: SCIMED LIFE SYSTEMS, INC., MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:G. DAVID JANG;REEL/FRAME:013559/0497

Effective date: 20021115

STCB Information on status: application discontinuation

Free format text: EXPRESSLY ABANDONED -- DURING EXAMINATION